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The Effects of Non-Surgical Interventions on Osteoarthritis-Like Changes in the
Mouse Knee
Wendy K. Anemaet
ABSTRACT
Osteoarthritis (OA) is a debilitating condition affecting over 21 million
persons in the United States. This number is expected to rise in the coming
decades. Treatment approaches for OA focus on symptom modifying measures
(i.e., pain relief) as disease modifying interventions do not currently exist.
However, some of the interventions used to alleviate the symptoms of OA are
also thought to have disease-modifying benefits. Two such non-surgical
interventions for OA are intra-articular hyaluronan (HA) injections and physical
exercise. In order to effectively study their effects in human OA, animal models
that are amenable for studying intervention outcomes are needed.
The research focused on developing and characterizing a progressive
non-surgical model of knee OA in adult mice. This model was used to firstly,
examine the capacity of intra-articular HA injections to prevent knee joint
degeneration, and secondly to examine the capacity of moderate exercise to
prevent onset and progression of joint degeneration.

ix

Intra-articular injections of TGF-β1 into murine knees produce synovial
hyperplasia, osteophyte formation, and fibrotic changes on cartilage surfaces and
joint capsules. However, additional exposure of the joints to high intensity
treadmill running (biomechanical overuse) results in more widespread and focal
OA-like cartilage erosions of both the tibial and femoral surfaces, similar to that
described for the pathological appearance of late human knee OA. Taken
together, these data support that synovitis and soft-tissue activation in early OA
joints may precede and/or accelerate the process cartilage degeneration
characteristic of progressive and late stage osteoarthritis.
Intra-articular injections of high molecular weight HA one day following
TGF-β1 injections resulted in decreased synovial hyperplasia, minimized
osteophyte formation, and significantly decreased severity of cartilage lesions. A
four week, alternate day, low intensity aerobic treadmill running program prior to
TGF-β injections and overuse also resulted in decreased severity of cartilage
lesions.
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Chapter One
Background and Literature Review
Overview of Osteoarthritis
Definition
Osteoarthritis (OA), also known as degenerative joint disease (DJD), is a
musculoskeletal disease that is diagnosed both structurally and clinically.
Structurally, synovitis (Benito et al., 2005), progressive articular cartilage loss
(Cahue et al., 2004; Cerejo et al., 2002), osteophyte formation (Boegard et
al.,1998), and subchondral sclerosis (Yamada et al., 2002), generally in weight
bearing joints such as knee and hip, give rise to biomechanically unstable joints
that result in loss of function (Sharma et al., 2001). The resulting abnormal
biomechanical forces on the joint tissues play a role in the erosion of cartilage
surfaces as well as subchondral sclerosis.
Clinically, patients with OA experience pain, stiffness, loss of motion,
weakness, and joint instability, all leading to functional limitation and disability
(Altman et al., 1986). However to date, criteria to precisely stage the severity of
the disease for treatment options remain ill defined (Boegard et al., 1998;
Creamer et al., 1999; Felson et al., 2000a; McAlindon et al., 1992; O’Reilly et al.,
1998; Peterson et al., 1996; Weidow et al., 2006). For example, persons may
report a high level of pain with only mild radiographic changes, or conversely,
may have dramatic radiographic changes with minimal reports of pain.
1

Development and application of assays of OA-specific biomarkers for
synovial fluid, serum and urine have been the focus of active clinical and basic
science research efforts, but have not yet resulted in clear marker panels that
could be readily used in diagnosis and prognosis of OA in the clinic or in
translational research studies (Bauer et al., 2006; Giles et al., 2007; Girling et al.,
2006; Kloppenburg et al., 2007; Krause et al., 2006; Lohmander and Eyre, 2005;
Nemirovskiy et al., 2007; Sumer et al., 2006; Thonar et al, 1993).

Incidence and Prevalence
Clinical diagnosis of OA is made in one in three persons over the age of
50 years, and women are more frequently affected than men (Lawrence et al.,
1998). OA is the leading cause of chronic disability in the elderly (Felson et al,
2000), owing in part to improved longevity. One in two persons over the age of
70 years and over 85% of persons aged 80 years or more have a clinical
diagnosis of OA (National Centers for Health Statistics, 2004). The most
commonly affected joint is the knee, but OA also affects the hip, spine, hands,
and feet (Glass, 2006). Incidence and prevalence vary slightly by the affected
area. Women have higher incidence and prevalence of hand and knee OA and
men have higher prevalence of hip OA (Jordan, 1996).

2

Etiology of Osteoarthritis
Genetics
Genetic defects of connective tissue structural and regulatory proteins,
such as bone morphogenetic protein 2 (BMP2), cartilage intermediate layer
protein (CILP), frizzled related protein (FRZB),and TNF alpha-induced protein
(TNFAIP6) have been clearly implicated in the development of OA and are often
associated with increased risk of OA (Lane et al., 2006; Valdes et al., 2004). For
example, mutations in humans that increase susceptibility to OA involve
collagens II (Vikkula et al, 1994), IX (Olsen, 1997), and XI (Jacenko and Olsen,
1995) genes and are often manifested as multiple joint involvement (Abel et al.,
2006; Bateman, 2005; Clements et al., 2006; Hakim and Sahota, 2006;
Lopponen, et al., 2004; Roughley et al., 2006; Williams and Jimenez, 2003;
Zhang and Doherty, 2005). However, while genetic linkages to OA exist, the
disease is rarely caused by a single genetic defect (Zhang et al., 1998), but
instead can be considered a multi-genetic, multi-factorial class of diseases. (See
Figure 1).
Injury
About 10% of all OA cases are post-traumatic in origin (Marsh, 2004),
including articular fractures (Furman et al., 2006), work or sports related overuse
of joints (Hansen and Reed, 2006; Hunt, 2006; McMillan and Nichols, 2005), and
injuries to the anterior cruciate ligament and/or menisci (Bartz and Laudicina,
2005; Koh and Dietz, 2005; Roos, 2005).
3

The precise etiology of post-traumatic OA remains to be determined as
individuals with no joint trauma and little repetitive activity also develop OA
(Hannan et al., 1993; Schrier, 2004). Moreover, exercising or involvement in
sports in the absence of muscular imbalances or physical damage to joint tissues
does not result in increased OA (Cymet and Sinkov, 2006; Schrier, 2004). Thus,
it is more likely that the extensive remodeling of joint tissues (synovium, cartilage,
bone, ligament, meniscus) which occurs in response to injury generates the
metabolic disturbance in the whole joint that eventually leads to the pathological
manifestation of OA (Felson, 2004).
Obesity
Obesity has been found to be strongly linked to knee OA (Cooper et al.,
2000; Schouten et al., 1992). Persons who were overweight at age 37 (when
knee OA is uncommon) had an increased risk of developing knee OA at age 70
or older (Felson et al., 1988). In women between 20-89 years with a body mass
index (BMI) of > 25 kg/m2, a new diagnosis for symptomatic knee OA was fourto ninefold higher than for age-matched controls with BMI < 25 kg/m2 (Felson,
1990). In addition, obesity is linked to enhanced progression of OA as defined by
radiographic changes (Schouten et al., 1992; Spector et al., 1994) and may
result in increased joint pain and disability (Jinks et al., 2006; Mallen et al., 2007;
Verbrugge et al., 1991).
It has been suggested that accumulation of adipose tissue results in
altered levels of hormones, cytokines, and growth factors, increased bone
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density, and changes in immune response (such as prolonged low grade
inflammatory response), and all of the above may have a role in OA development
(Nevitt and Felson, 1996; Olson et al., 2007). In addition, weight gain is common
in persons with decreased functional status and/or disability, all hallmarks of OA
and aging, potentially enhancing disease progression further in such individuals
(Lievense et al., 2002).
Aging
Both the incidence (number of new cases in a specific period of time) and
prevalence (the number of cases in a population at a given time) of OA increase
in the elderly (Kopec et al., 2007). A common initiating factor in OA is the
inability of the joint to repair mechanical (trauma) or metabolic (obesity) injuries
(Olson and Marsch, 2004) during which cellular and biochemical pathways,
including immune responses, are activated for tissue repair (Polyzois et al.,
2006). Immunosenescence, therefore, may be an important factor in promoting
pathogenesis of OA in the elderly. Age-related changes in the innate and
acquired immune pathways manifest themselves in chronic inflammation and
inefficiency in immune surveillance (Senchina and Kohut, 2007), including agerelated changes in function of neutrophils and macrophages (Fulop et al., 1997;
Gomez et al., 2005: Lord et al., 2001; Plackett et al., 2004; Stout and Suttles,
2005; Wenisch et al., 2000). As a result, older adults are more vulnerable to
infection (Crichton and Puppione, 2006), and wound healing is slow or even
impaired. Moreover, circulating levels of pro-inflammatory mediators including
5

interleukin (IL)-1, IL-6, tumor necrosis factor-alpha (TNF-α), prostaglandin, and
C-reactive protein (CRP) can occur in the elderly (Franceschi et al., 2000).

Pathogenesis of Osteoarthritis
The pathogenesis of OA involves interactions of joint tissues, joint
biomechanics, and biochemical pathways. The predominant pathological
features of OA are synovitis and fibrosis, accelerated bone remodeling with
ostoephyte development, and articular cartilage degeneration. As outlined above,
underlying characteristics, such as age, genetic background, and comorbidities
(obesity) predispose an individual to the development of OA. In conjunction with
aberrant joint biomechanics in the form of injury, overload, or joint instability, this
predisposition may lead to altered biochemical pathways including those involved
in cytokine and growth factor signaling, or matrix biosynthesis and turnover.
These altered pathways lead to the development and progression of tissue
damage in OA which present clinically as radiographic changes in bone and
cartilage and joint pain. The presentation of pain is also affected by psychosocial
and socioeconomic factors (Thumboo et al., 2002) as well as the presence of comorbidities (Tuominen et al., 2007). The presence of pain, in turn, may act to
alter biochemical pathways leading to further development and progression of
OA. In addition, pain leads to disability and distress which lead to increased pain
perception (Figure 1).
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Figure 1: Representation of complex relationship between environmental and
endogenous risk factors for joint damage, osteoarthritis, and joint pain and their
consequences

(From: Dieppe and Lohmander, 2005)
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The Human Knee Joint
The mammalian knee joint is comprised of two long bones, the tibia and
the femur, and a sesamoid bone, the patella (Figure 2). The patella serves as a
pulley allowing the quadriceps muscle to act more efficiently, sliding in the
femoral sulcus.
Three major muscle groups control movement at the knee. The
quadriceps is comprised of four muscles (the vastus lateralis, the vastus
intermedius, the rectus femoris, and the vastus medialis). This muscle group is
responsible for knee extension and is contiguous with the extensor mechanism
(comprised of the patella tendon, patella, and patella ligament). Muscle
imbalances, especially weakness of the vastus medialis, results in abnormal
tracking of the patella. Abnormal pulling of the quadriceps muscle (from muscle
imbalance or structural abnormalities) in other joint tissues results in the patella
moving out of the femoral sulcus. The distal end of the femur, proximal end of the
tibia, and posterior aspect of the patella are lined with articular cartilage. When
the patella tracks abnormally, damage to the articular cartilage on the femur and
patella may occur (Cahue et al., 2004; Sharma et al., 2001; Sharma et al., 2003).
The hamstrings consist of the semimembranosus, the semitendinosus,
and the biceps femoris and all three are responsible for knee flexion. In addition,
the hamstrings protect the integrity of the anterior cruciate ligament by
counteracting shear through controlling anterior movement of the tibia on the
femur. The third muscle acting at the knee is the gastrocnemius which is
primarily responsible for ankle plantarflexion, but also assists with knee flexion.
8

Figure 2: Schematic of the knee joint (patella reflected)

(Diagram by Arnheim and Prentice accessed at http://factotem.org/library)
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Ligaments about the joint provide stability. The patella ligament connects
the patella and quadriceps muscle to the tibia at the tibial tuberosity and provides
anterior-posterior stability to the joint. The anterior cruciate ligament (ACL) and
posterior cruciate ligament (PCL) cross at the center of the joint (Figure 2)
connecting the tibia to the femur. They are intra-articular ligaments because they
are within the joint capsule and surrounded by synovial fluid. They protect the
knee against twisting and control forward sliding of the tibia on the femur (shear).
The medial collateral (MCL) and lateral collateral (LCL) ligaments are located on
the medial and lateral sides of the knee, respectively (Figure 2). They connect
the femur to the tibia on the medial side and fibula on the lateral side. The MCL
protects the knee against valgus (inward) forces and the LCL protects against
varus (outward) forces.
Menisci are two crescent-shaped pieces of fibrocartilage between the
femoral and tibial surfaces (Figure 2). They cushion the joint from impact and
distribute compressive and shear forces across the articular cartilage surfaces.
Biomechanically the knee is at risk for injury as a result of the high torque
moments created by the long bones and the frequency of use of the lower
extremities. Dynamic loading of the joint (walking, running, and jumping) can
increase joint forces up to 20 times relative to just standing. In addition, rapid
changes of motion that occur with many activities as well as balance corrections
require quick changes in velocity and impose additional stresses on supporting
structures of the knee.

10

The Synovium
The synovial membrane is the delicate, vascularized tissue that covers the
non-articular surfaces of the synovial joint cavity, including intra-articular
ligaments (the anterior and posterior cruciate and patellar ligaments), the patellar
tendon, and the intra-capsular bone surfaces (Figure 3). It is composed of an
epithelial-like cell lining facing the joint cavity (intima), and a deeper, vascularized
fibrous layer (subintima) that can also contain groups of differentiated fat cells.
Synovial functions include innate immune surveillance, lubrication, and intraarticular joint tissue nutrition, representing a metabolic protection of joint function
(Berumen-Nafarrate et al., 2002).
The synoviocytes in the lining have been defined ultra-structurally as Type
A (macrophage-like) cells and Type B (fibroblast-like) cells (Pavolich and
Lubowitz, 2008). Type A cells function as resident tissue macrophages to remove
cell debris and products of macromolecular turnover processes which include
synovial fluid hyaluronan (HA; Bondeson et al., 2006) lubricin, collagen, and
aggrecan fragments. Type B cells are the major producers of HA and lubricin for
the synovial fluid that decrease the joint friction coefficient reducing forces on the
articular cartilage (Schmidt et al., 2007; Smith et al., 2003).
Alteration in cell and matrix constituents of the synovium, which is also
known as synovitis, has been reported to correlate with progression of OA. Thus
the pathological synovium may to a large extent be responsible for production of
pro-inflammatory cytokines (interleukins, TNF and oncostatin M) and growth
factors (platelet derived growth factor [PDGF], transforming growth factor-beta
11

[TGF-β1]). (Bondeson et al., 2006; Sutton et al., 2007) These in turn may
regulate the expression of other pro-inflammatory pathways leading to the
production of tissue destructive proteases including collagenases and a
disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)
proteases (Fukui et al., 2005; Youn et al., 2002).

12

Figure 3: Location of the synovium and synovial fluid within the knee joint

posterior

anterior

From http://www.healthcare.utah.edu/healthinfo/images
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Bone
Bone matrix is primarily composed of calcium hydroxylapatite deposited
within a collagen matrix. The mineral provides compressive strength and the
collagen provides elasticity. The outer layer of cortical bone accounts for 80% of
the total bone mass and a cell-rich porous network of rod- and plate-like
trabecular bone accounts for the remaining 20% of the total bone mass (Figure
4). Trabecular bone, however, has about ten times the surface area of cortical
bone and its porous network harbors blood vessels and marrow. The periosteum
is a thin layer of connective tissue on the outer surface of bones. It has
nociceptive nerve endings, provides the blood supply to the cortical bone, and
contains progenitor cells that are activated during fracture healing (Fiedler et al.,
2002).
Bone contains two major cell types (Figure 5): osteoblasts are boneforming cells that make osteoid, a protein mixture of type I collagen,
proteoglycans, and glycoproteins which mineralizes to become bone; and,
osteoclasts are large multi-nucleated cell on the bone surfaces responsible for
bone resorption (You et al., 2008).

14

Figure 4: Structure of bone

15

Figure 5: Bone cell associations
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Bones function to protect internal organs, build the skeleton to support
the body, and produce movement in conjunction with muscles. In addition bones
act as storage sites for minerals, especially calcium and phosphorus, and contain
the hemapoeitic (blood) cell development within the marrow. Bone can also
buffer the blood against pH changes by absorbing or releasing alkaline salts and
can chelate heavy metals thereby removing them from the blood and minimizing
their toxicity on other organs of the body (Mutlu et al., 2007).
Several investigators have proposed that alteration in bone metabolism
may play a role in the initiation and progression of OA (Botter et al., 2007;
Muraoka et al., 2007; Radin, 1999; Sniekers et al., 2008). For example, recent
studies looking at collagen synthesis and degradation reported an imbalance in
those processes that may cause some of the OA-associated subchondral bone
changes including subchondral sclerosis (Bailey et al., 2004; Day et al., 2004).
Osteophyte formation at joint margins in OA joints (Boegard et al., 1998)
are another indication of bone adaptation associated with OA. Osteophytes
develop in joints constrained by a joint capsule lined with synovium (van der
Kraan and van den Berg, 2007). Mesenchymal progenitor cells within the
periosteum (Figure 4) and the synovial lining (Figure 3) are involved in the
development of osteophytes (Shirasawa et al., 2006). Their proliferation and
migration followed by chondrogenic differentiation and cartilaginous matrix
accumulation at the epiphyseal margins of bone and cartilage have been well
described (van der Kraan and van den Berg, 2007). (See Figure 5). Subsequent
17

chondrocyte hypertrophy and endochondral ossification forms the mature
osteophyte. TGF-β1 and insulin-like growth factor (IGF)-1 are both involved in the
formation of osteophytes (van der Kraan and van den Berg, 2007; Okazaki et al.,
1999), as are growth factors such as BMP-2 and BMP-4, and these are also
typically products of macrophages (Blom et al., 2004; van Lent et al., 2004).

Articular Cartilage
Articular cartilage is a specialized connective tissue composed of an
abundant extracellular matrix (ECM) and metabolically active cells, the
chondrocytes. The chondrocytes in adult articular cartilage are responsible for
producing and organizing the extracellular matrix in response to the normal
physical-chemical demands generated by usage of the tissue during joint
movement (Iannone and Lapadula, 2003). The extracellular matrix of cartilage is
composed primarily of collagens II, IX, and XI and the proteoglycan aggrecan. In
turn, by forming supramolecular complexes (collagen fibrils and
proteoglycan/hyaluronan aggregrates) they provide the tissue with its viscoelastic
properties to resist compression and dissipate sheer forces imposed on cartilage
surfaces during articular joint usage.
Four distinct, histological zones have been identified in human cartilages
(Figure 6). The superficial tangential zone is the outer layer facing the synovial
cavity. It has the highest collagen content (85% by dry weight) and comprises 1020% of the cartilage thickness. Chondrocytes in this superficial zone are
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elongated and collagen fibrils are oriented parallel to the joint surface which may
help to resist shear forces (Carter and Wong, 2003).
The transitional zone makes up about 60% of the cartilage thickness and
contains less collagen (68% by dry weight) but abundant proteoglycan compared
to the superficial tangential zone. Collagen fibers are larger in diameter and are
more randomly oriented. Residual chondrocytes have a round morphology.
The deep zone comprises 30% of the cartilage thickness and has collagen
fibers oriented perpendicular to the subchondral bone. Chondrocytes are round
and arranged in columns. A calcified cartilage zone is at the interface with the
bone, with few chondrocytes. This region also contains the calcified “tidemark”
region that functions as a barrier to vascular penetration from the subchondral
bone region (Langworthy et al., 2004).
Substantial efforts over the past several decades were directed towards
understanding the molecular and cellular mechanisms by which the structural
components of articular cartilage are irreversibly destroyed and result in
progression of OA. Briefly, collagen fibrils are degraded by matrix
metalloproteinase collagenases (MMPs) (Davoli et al., 2001; Pratta et al., 2003;
Smith, 2006; Tardif, et al., 2004), whereas aggrecan molecules are substrates for
ADAMTS proteases (Gao et al., 2004; Nagase and Kashiwagi, 2003; Sandy,
2006; Sandy and Verscharen, 2001; Song et al., 2007). Despite the extensive
work on the protease identification, little is known about the temporal and spatial
regulation of their activities in normal tissue turnover and OA (Cawston and
Wilson, 2006; Sandy, 2006).
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ADAMTS metalloproteases cleave aggrecan, a major component of
cartilage extracellular matrix in human OA. It remains open which aggrecanase is
responsible for aggrecan destruction during articular cartilage degeneration in
human OA (Song et al., 2007; Tortorella and Malfait, 2008). However, the
generation and use of ADAMTS-5 knockout (KO) mice demonstrate that activity
of this enzyme is required for progression of OA-like cartilage lesions in mouse
knees surgically destabilized by MCL transection (Glasson et al., 2005) or
challenged by antigen-induced arthritis (Stanton et al., 2005). Increased
accumulation of ADAMTS-5 in human OA cartilage compared to normal agematched tissues has also been reported and supports a role for this enzyme in
the pathogenesis of human OA (Plaas et al., 2007).
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Figure 6: Zones of articular cartilage

From http://www.chelationtherapyonline.com/articles/p179.htm

S = superficial zone; M= middle zone; D = deep zone

From: http://www.nomranmarcusmd.com/research.html
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Assessment of Cartilage Degeneration
Several in vivo techniques have been developed to diagnose and monitor
the progression of cartilage degeneration. Radiographs are commonly taken, but
they are unable to delineate cartilage directly because of lack of sensitivity to
detect soft tissue contrast. They are commonly used to measure joint space
width, an indirect assessment of cartilage thickness (Scott et al., 2007).
Arthroscopy allows a direct view of cartilage and is considered the most reliable
method for cartilage assessment (Lee et al., 2007). However, it is an invasive
procedure potentially leading to post-surgical complications of infection and
unintended joint injury. In addition, arthroscopy is expensive making it unsuitable
as a global evaluative technique (Forssblad et al., 2004). Non-invasive imaging
methods include computed tomography (CT), magnetic resonance imaging
(MRI), and ultrasonography (US). CT, with and without contrast, produces
images in the transverse plane (perpendicular to the direction of weight bearing),
but cartilage over the weight bearing area of the knee cannot be directly viewed
(Mackay et al., 2006). Current MRI techniques allow measurement of cartilage
thickness (Burstein and Gray, 2006). They provide detailed images of tissue
structure regardless of the plane by measuring levels of metabolites in cartilage
and achieve superior soft tissue contrast compared to CT. MRI is able to detect
cartilage abnormalities and meniscal injuries with the same resolution and clarity
as arthroscopy (Hyusse and Verstraete, 2007). MRI can also be enhanced by
injection of ionic gadolinium into the joint (Roos and Dahlberg, 2005). Healthy
cartilage which is rich in negatively charged aggrecan repels the contrast while
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degenerating cartilage with substantial aggrecan loss shows signal enhancement
because it does not repel the contrast (Roos and Dahlberg, 2005). The
usefulness of MRI in detecting and classifying cartilage degradation may also be
improved by the development of on-line databases, such as morphological
atlases of knee cartilage, and using shape indices as a means of classification
(Tameem et al., 2007). Ultrasound correlates significantly with histological
grading and continues to be studied to determine if it provides a non-invasive,
cost-effective technique for accurately assessing cartilage quality (Lee et al.,
2007).

Histological Grading of Cartilage in Human OA and in Animal Models
Cartilage tissue taken in animal studies or post-surgically in human studies can
be graded based on its macroscopic and microscopic appearance. Noted
pathological features include surface roughening, fissure development,
delamination of the surface, cavity formation, tissue fragmentation, and
fibrocartilage growth (Pritzker et al., 2006). A macroscopic classification system
grades OA as Grades I-IV based on qualitative descriptions of the texture of the
cartilage surface, the size of cartilage lesions, and changes in the subchondral
bone (Collins et al., 1949). A 14-point microscopic grading system using
histological stains, such as Safranin O with light green counterstain, is based on
cellular changes, presence of Safranin O cartilage matrix staining, and changes
such as erosion and vessel penetration. The Osteoarthritis Research Society
International (OARSI) system is a 24-point score using six grades (based on
23

depth of progression into the cartilage) and/or four stages (based on percentage
of involvement; Pritzker et al., 2006).
India ink wash of the joint surfaces allows further observation of cartilage
surfaces and provides a means of quantifying the degradation based on the
amount of India ink present (Chang et al., 1997; Kobayashi et al., 2000; Lewis et
al., 2005; Stoker et al., 2006). Applying India ink highlights surface abnormalities
of the articular cartilage. The India ink carbon particles (diameter 40-100 nm;
Madsen et al., 1992) do not enter normal articular cartilage due to its small
average pore size of ~6 nm (Maroudas, 1979 ) but does become entrapped in
surface irregularities and adhere to the fibrillated cartilage (Meachim et al., 1972)
thus appearing as darkly stained areas.

Clinical Treatment for Osteoarthritis
The current treatment modalities for OA are largely intervention-based, as
they address symptoms only. Disease “cures” have not been successfully
developed. Therapeutic approaches range from psychosocial, pharmacological,
and physical therapy interventions to surgical replacements of degenerated
joints. Effective long-term management of the disease proposes involvement of a
sequential approach, the details of which are based on disease severity at the
time of diagnosis. Such treatment strategies ideally begin with information and
education at the earliest stages of disease diagnosis. This is followed by self help
interventions (including analgesics) then progresses to simple [non-steroidal antiinflammatory (NSAID) medications, corticosteroids, and physical and
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occupational therapy] and advanced (injections) non-surgical interventions.
Finally, application of surgical procedures may be warranted (Figure 7). These
treatment interventions and studies that have evaluated their efficacy are
reviewed briefly in the following sections

Psychosocial Interventions
Psychosocial interventions such as patient education techniques and
lifestyle modifications are commonly used in other chronic diseases such as
diabetes (Delamater et al., 2001), obesity (Cresco et al., 2007), and
cardiovascular (Patel and Adams, 2008) and neurodegenerative (Martial and
Donahue, 2006) disorders. Similar approaches have been developed for OA and
are utilized in many parts of the world in the treatment of OA. An education self
help program was compared with “care as usual” in 273 persons with hip and/or
knee OA to determine the effects on pain, other complaints (such as stiffness
and loss of movement), and functional limitations. The patient group using the
self help program reported decreased pain and improved function when
compared to the “care as usual” controls as early as three months after starting.
They reported improvements throughout a 21 month follow-up (Heats et al.,
2005). Another study investigated the effects of coping skills training on
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Figure 7: Sequential pyramidal approach to OA management

(From: Dieppe and Lohmander, 2005)
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descending modulation of nocioception via the nociceptive flexion reflex (NFR) in
persons with knee OA. The NFR results in withdrawing from a noxious stimulus
mediated along the A-delta and C fibers which extend to the dorsal horn spinal
neurons where the signal is modulated. The NFR threshold is correlated with
subjective pain threshold. The intervention significantly increased NFR
thresholds and decreased pain ratings (Emery et al., 2006).
Educational interventions such as therapeutic education and functional readaptation (TEFR) have also been tested for positive effects on health related
quality of life. For example, a study of persons with knee OA on a wait list for
total knee replacement comparing TEFR plus pharmacological treatment to
pharmacological treatment alone found significant improvements in the Western
Ontario and MacMaster’s University Osteoarthritis Index (WOMAC) function
score, pain, and physical function as measured by the Short Form Health Survey
General Questionnaire (SF-36; Nunez et al., 2006).
In another study the effects of the Arthritis Self Management Program
(Lorig et al., 1985) and the Chronic Disease Self Management Program (Lorig et
al., 1999) on quality of life, health behaviors, self efficacy, and health care
utilization was assessed. Both intervention programs demonstrated positive
outcomes in all measures. However, the arthritis-specific program had better
results at earlier time points than did the general chronic disease program (Lorig
et al., 2005).
Specific lifestyle modifications, such as weight loss, have been shown to
be efficacious in some persons with OA. One study involving a group of women
27

with a BMI < 25 showed that neither weight loss nor weight gain affected the risk
of knee OA later in life. In a second group of women with BMI > 25, a weight loss
of 12 pounds significantly lowered (>50%) the rate of knee OA. Further, in the
group with BMI >25 weight gain was associated with an increased rate of knee
OA later in life (Felson, 1990),
Similar findings were reported in a study of women who experienced knee
pain and were overweight. An average weight loss of 15 pounds using a six
month diet and walking intervention resulted in improved knee pain, decreased
lower extremity disability, better vO2 maximum, and greater six minute walk
distance compared to baseline (Martin et al., 1996). A study of older adults (men
and women aged 60 and older) with obesity and symptomatic knee OA reported
that diet plus exercise and exercise alone led to decreased knee pain and less
disability after the six month interventions (Messier et al., 2004). Furthermore,
individuals in the diet plus exercise group lost 15 pounds more than those in the
exercise alone group and had better improvements in knee-related disability.

Pharmacological Interventions
Oral Medications
Acetaminophen has been used for decades to treat symptoms of OA.
Studies on less than 60 subjects for 6 weeks or less published in the 1980s and
1990s reported acetaminophen was better than placebo for pain relief in persons
with OA (Amadio and Cummings, 1983; Zoppi et al., 1995). Due to its excellent
safety record, large clinical trials which found a benefit of acetaminophen over
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placebo (Miceli-Richard et al., 2004; Pincus et al., 2004), and meta-analyses
showing a small effect size (Neame et al., 2004; Zhang et al., 2004),
acetaminophen is still recommended as a first line treatment for pain associated
with OA.
NSAIDS (ibuprofen, naproxen, nabumetone) are generally effective for
pain relief in persons with OA. However, they may induce gastrointestinal or
other complications (such as electrolyte imbalance, dizziness, and increased
blood pressure) associated with long term use (Richy et al, 2004). NSAIDS have
been reported to be marginally better than acetaminophen for pain relief (Eccles
et al., 1998; Zhang et al., 2004), but little or no difference has been reported
between formulations (Gotzsshe 2003; Scott et al., 2003). Given the higher rate
of adverse effects associated with NSAIDS, they are added only if
acetaminophen does not sufficiently relieve symptoms.
To address the issue of gastrointestinal side effects, cyclo-oxygenase 2
(COX-2) selective inhibitors were introduced as a new generation of NSAIDS.
While studies demonstrated effectiveness in pain relief, the moderately selective
COX inhibitors did not have better gastrointestinal safety (Ju’ni et al., 2002) and
the highly selective COX inhibitors led to increased cardiovascular adverse
events (Ju’ni et al., 2004).
Injectable Agents
Pharmacologic agents can also be delivered directly into the affected joint
directly via an intra-articular injection. For example, corticosteroid injections for
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short term pain relief during “inflammatory flares” of OA have been used to assist
with physical therapy (Arroll and Goodyear-Smith, 2004). A meta-analysis of
randomized controlled trials showed 1-4 weeks of pain relief after intra-articular
injections of corticosteroids into OA knee joints (Arroll and Goodyear-Smith,
2004). However, a poor understanding of the detrimental effects of corticosteroid
injections on the metabolic and structural integrity of joint tissues impedes on
their usefulness as safe and reliable therapeutics (Divine et al., 2006).
A large number of studies have shown that intra-articular injections of HA
decrease pain and improve functional outcomes in knee OA (Altman and
Moskowitz, 1998; Huskisson and Donnelly, 1999; Kotz and Kolarz, 1999;
Leardini, et al., 1987; Puhl et al., 1993; Wobig et al., 1998). HA is a high
molecular weight polysaccharide composed of repeating disaccharide units of
glucuronic acid and N-acetylglucosamine. It is produced by all cells in the body
and secreted into the extracellular space with molecular weight s from 1-7 million
Daltons. In articular joints, Type B cells in the synovial lining synthesize and
secrete HA into the synovial fluid (Laurent et al., 1996) at a steady state
concentration of 2-4 mg/ml (Balazs and Denlinger, 1993). Its high viscoelastic
properties provide lubrication during slow joint movements and shock absorption
during rapid joint movements (Brandt et al., 2000). Studies in the 1980s reported
that HA concentration and size were reduced in synovial fluid collected from
persons with OA of the knee (Dahl et al., 1985). Similar findings were reported in
human temporomandibular joint disease as well (Takahashi et al., 2004). This led
to postulation that intra-articular injection of HA may act to restore the
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viscoelasticity and the lubricating functions in an HA-depleted joint (Balazs and
Denlinger, 1993).
HA can also exert regulatory effects on cells through interaction with a
range of HA receptors (CD44, toll-like receptors, LYVE-1, stabilin) (Nehls and
Hayen, 2000). Such receptor interactions may lead to downstream inhibition of
prostaglandin E2 production (Yasui et al., 1992) and also provide protection
against free radical cytotoxicity (Presti and Scott, 1994), altered inflammatory cell
adherence, proliferation, migration, and phagocytosis (Ghosh, 1994).
The potential disease-modifying effects of intra-articular injections of HA
may also work through the cell modifying pathways. Pain relief after three to five
weekly, intra-articular injections of HA is reported to last from six months to a
year (Altman and Moskowitz, 1998; Arrich et al., 2005; Bellamy et al., 2006;
Huskisson and Donnelly, 1999; Kotz and Kolarz, 1999; Leardini, et al., 1987; Lo
et al, 2003; Modawal et al., 2005; Puhl et al., 1993; Wang et al., 2004; Wobig et
al., 1998) This is longer than its half-life (18-24 hours) within the joint (Kotz and
Kolarz, 1999).
In vivo studies of human synovial fluid demonstrated decreased numbers
of activated macrophages and lymphocytes (Corrado et al., 1995) and decreased
synovial effusion (Dougados et al., 1993) with HA injections. HA may therefore
have a local or systemic anti-inflammatory effect. Addition of HA to human
articular cartilage explants ex vivo showed inhibition of IL-1β stimulated
production of MMPs like MMP-1, MMP-3 and MMP-13 (Julovi et al., 2004).
Addition of HA to fibroblast-like synoviocytes resulted in decreased expression of
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ADAMTS-5 mRNA and this was accompanied by down-regulation of TNF-α, IL8,and inductible nitric oxide synthase (iNOS) (Wang et al., 2006).
It should be noted that HA is also used clinically to prevent post-surgical
adhesion development (Urman et al., 1991) in abdominal (Tsai et al., 2005) and
ophthalmic (Arshinoff et al., 2002) surgery. In addition, increased concentration
of HA in fetal wounds is one of the reasons for scarless wound healing (Mast et
al.,1992).
The wound healing actions of HA have been attributed to a proinflammatory effect necessary for the granulation, re-epithelialization, and
remodeling stages of wound healing. Its cellular effect enhances proinflammatory cell infiltration (Wisniewski et al., 1996), and increases local
production of TNF-α, IL-1β, and IL-8 (Kobayashi and Terao, 1997). In addition
HA can also augment the granulation phase of healing through enhancing cell
migration (Ellis and Schor, 1996) and angiogenesis at the site of tissue damage
(Deed et al.,1997).
In summary, the symptom-modifying effect of intra-articular HA in persons
with OA may alter synovial cell proliferation, differentiation, and apoptosis and
secondarily inhibit expression of pro-inflammatory signaling molecules and
proteases in the joint that eventually lead to matrix destruction, as opposed to
repair, in an OA joint (Goldberg and Buckwalter, 2005).
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Physical Therapy Interventions
Physical therapy for the treatment of OA aims to correct joint
biomechanics and provide symptom relief via orthotics and bracing, modalities,
and exercise. The overall goal is to maximize functional capabilities while
minimizing pain and trauma to soft tissues, bone, and cartilage surfaces
(American Physical Therapy Association, 2003). These interventions are rarely
used in isolation, but instead are used in conjunction with psychosocial and
pharmacologic interventions.

Orthotics and Bracing
Orthotics and braces can change joint biomechanics and redistribute joint
forces. The most frequently used orthotic in OA treatment is a lateral wedge
which places the ankle and foot in less supination resulting in decreased stress
on the medial compartment of the knee. Outcomes from studies using orthotic
interventions vary depending on whether or not there was standardization of
shoes in which the orthotics were inserted. Using lateral wedge insoles in a twoyear study with persons with knee OA led to neither symptomatic (change in
WOMAC scores, need for injections or lavage, or self-assessed activity) nor
structural (joint space width) improvements, but a decreased number of days of
NSAID usage was reported (Pharm et al., 2004). A four week intervention of
lateral wedge insoles and standardized shoes gave significant improvements in
WOMAC pain, stiffness, and function scores (Fang et al., 2006). A third study
using an eight week intervention with elastic subtalar strapping reported
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radiographically detected decreases in femoritibial angle. Significant
improvement in pain during bed rest with full knee extension, upon getting up
from a seated position, and after getting up, as well as increased maximum
distance walked, and aggregate severity score were also reported (Toda and
Segal, 2002).
Knee bracing has also been utilized in an attempt to correct joint
biomechanics at the knee and thereby reduce unusual forces at this joint. Indeed,
knee valgus bracing improved disease-specific quality of life and function (Scott
et al., 2003), and taping the patella in a more medial orientation also resulted in
reduced knee pain (Cushnaghan et al.1994).

Modalities
Physical therapy modalities for the treatment of OA are used to decrease
pain and inflammation (Brousseau et al., 2004). They include thermal modalities
and electrical stimulation. Thermal modalities are primarily in the form of hot
packs, cold packs, and ice massage.
While a single application of ice packs placed on the anterior and posterior
knee did not significantly affect edema, ten sessions of cold pack application
resulted in a significant effect (Hecht, 1983). Hot pack application did not have
this effect. Twenty minutes of ice massage five times a week for two weeks was
also found to decrease pain and improve knee extension strength, range of
motion, and time to walk 50 feet (Yurtkuran, 1999).
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Electrical stimulation elicits muscle contraction via the placement of
electrodes on the skin (American Physical Therapy Association, 2003). This can
assist in muscle strengthening as well as improving blood flow to the treated
area. It has been suggested that the presence of the electrical current can attract
and repel the positively and negatively charged ions in the underlying tissues and
these may regulate a variety of cellular responses including inflammation and
pain pathways (Kloth, 2005).
Pulsed electrical stimulation has been shown to improve patient and
physician global evaluation and patient reported pain and reduce NSAID use by
> 50% (Farr et al., 2006; Garland et al., 2007). Neuromuscular electrical
stimulation has also been shown to decrease pain in persons with knee OA
(Gaines, et al., 2004).

Exercise
Therapeutic exercise is any activity designed to improve joint and/or
muscle performance (American Physical Therapy Association, 2003). It includes
aerobic/cardiovascular exercise, range of motion and flexibility, resistance
training, and functional exercise. Exercise has long been used as a treatment
intervention for persons with OA as it decreases joint pain and stiffness and
increases functional abilities (Ettinger et al., 1997). Appendix 3 summarizes OArelated exercise studies and their reported outcomes.

35

Aerobic Exercise
Aerobic exercises include walking programs or stationary bicycling, are
performed for at least 20 minutes at a time, and involve active movement that
increases the heart rate. While aerobic exercise utilizes muscle action, muscle
strengthening is not the primary objective. Aerobic exercise is generally
performed to improve fitness level by increasing the efficiency of the heart and
lungs with increasing activity. However, aerobic exercise also results in
movement of the joints, loading of the bones, and muscle use, all of which may
impact knee OA.
A large number of studies using aerobic exercise for persons with knee
OA are reported. They all show significant improvements in a variety of
functional, psychosocial, and pain measures. These measures include timed
chair rise, six minute walk test, (Mangione et al., 1999), medication use, walking
distance, function as measured by the Arthritis Impact Measurement Scale
(AIMS) physical activity subscale (Kovar et al., 1992), 50 feet walking time,
depression, anxiety, physical activity (Minor et al., 1989), walking speed,
disability scores (Penninx et al., 2002; Ettinger et al., 1997), depressive
symptoms as measured by the Center for Epidemiological Studies—Depression
Scale (Penninx et al., 2002), self-efficacy for stair climbing (Rejeski et al., 1998),
aerobic capacity (Mangione et al., 1999; Minor et al., 1989), and pain (Ettinger et
al., 1997; Kovar et al., 1992; Mangione et al., 1999; Penninx et al., 2002).
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Aerobic exercise did not increase daily reported pain, indicating this
repetitive lower extremity exercise does not exacerbate pain symptoms
(Mangione et al., 1999). Moreover, one study suggested that continuation of
aerobic exercise is necessary in order to maintain benefits as cessation lead to
outcome reports that were not were not significantly different from the nonexercising control group (Sullivan et al., 1998).
Indeed, several professional panels and consensus groups advocate
aerobic exercise for persons with OA. The American Geriatric Society (AGS)
Panel on Exercise and Osteoarthritis recommends aerobic exercise three to four
times a week for 20-30 minutes a day at a low to moderate intensity which is
further defined as 50-75% of the maximum heart rate or a rating of perceived
exertion (RPE) of 10-13 (AGS Panel on Exercise and Osteoarthritis, 2001). The
American College of Rheumatology (ACR) workgroup recommends 30 minutes
of moderate intensity aerobic exercise (50-70% of maximum heart rate) at least
three times a week (Altman et al., 2000). The MOVE consensus and the
European League Against Rheumatism (EULAR) also recommend the inclusion
of aerobic exercise for persons with OA, but do not make any recommendations
on intensity, frequency, or volume (Jordan et al., 2003; Roddy et al., 2005).
According to Bennell and Hinman, strengthening exercises appear
superior to aerobic exercise for persons with knee OA in improving physical
symptoms, such as pain, whereas aerobic exercise may be more effective for
functional outcomes over the longer term (Bennell and Hinman, 2005). However,
a systematic review of 13 randomized controlled trials found no difference
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between aerobic and strengthening exercise programs in their ability to reduce
pain and disability in the same population (Roddy et al., 2006).
Since aerobic exercise has components of the other types of exercise
(joint motion as in range of motion/flexibility exercise, strengthening to some
degree as in resistance training, and activities of daily living as in functional
exercise) investigating the benefits of aerobic exercise may provide a broad
picture of the effect exercise can have on OA.

Range of Motion/Flexibility Exercises
Range of motion and flexibility exercises involve movement of extremities
without resistance as well as stretching exercises aimed at increasing muscle
length and flexibility to increase the range of motion within a joint. There are no
studies specifically evaluating the effect of range of motion/flexibility exercises on
persons with OA. Instead, these exercises are typically combined with other
types of exercise (aerobic, resistance, and functional) for individuals with OA
(Minor et al., 1989)

Resistance Exercises
Resistance exercises for OA involve moving a body part against an
external force. This force ranges from bodyweight to low intensity (less than 20%
of the maximum load a person can move through the full arc of movement) to
high intensity (up to 85% of the maximum load a person can move through the
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full arc of movement). Examples of such exercises are tightening the quadriceps
muscle with the knee extended, standing up from a chair, using a knee extension
or leg curl machine, and extending the knee in a seated position with weights
around the ankle are all examples of resistance exercise. The amount of
resistance is quantified by determining the maximum force an individual can
generate or maximum load an individual can move during the exercise.
Resistance exercises strengthen the muscles around an affected joint and
thereby may improve muscle balance and joint biomechanics lessening stress on
the joint tissues. In addition, resistance exercises result in joint movement and
bone loading which may impact knee OA.
Resistance exercises have shown positive benefits for persons with OA in
the following outcome categories: increased strength (Ettinger et al., 1997;
Eyigor et al., 2004; Gur et al., 2002; Penninx et al., 2002; Schilke et al., 1996;
Topp et al., 2002; Topp et al., 2005), decreased pain (Ettinger et al., 1997; Eyigor
et al., 2004; Gur et al., 2002; Penninx et al., 2002; Schilke et al., 1996; Topp et
al., 2002), decreased stiffness, and arthritis activity as measured by the
Osteoarthritis Severity Index (OASI) and the AIMS (Schilke et al., 1996),
improved function (Ettinger et al., 1997; Eyigor et al., 2004; Gur et al., 2002;
Penninx et al., 2002; Schilke et al., 1996; Topp et al., 2002; Topp et al., 2005 ),
less disability, decreased depressive symptoms (Ettinger et al., 1997; Penninx et
al., 2002), decreased disease severity, and improved WOMAC, SF-36, and
AIMS-2 scores (Eyigor et al., 2004).
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Improving muscle strength, especially of the quadriceps, may be very
important in preventing disease progression. Slemenda et al., found that women
with stronger quadriceps had a reduced risk of developing radiographic evidence
of knee OA as compared to those with weaker quadriceps (Slemenda et al.,
1998). This finding was confirmed by Hootman et al, who looked at 3081
community dwelling adults without OA and found that women with moderate to
high isokinetic quadriceps strength had a 55% reduced risk of developing hip OA
and a 64% reduced risk of developing knee OA (Hootman et al., 2004). A strong
quadriceps muscle may provide joint protection and decrease abnormal wear on
the cartilage surfaces.
Increased hip abduction strength is also associated with decreased knee
OA progression (Chang et al., 2004). Hip abductors originate on the pelvis above
the hip joint and attach on the lateral leg just below the knee. As a result, they
have a stabilizing effect on the pelvis and influence toe out angle during gait
minimizing abnormal stress on the knee. Conversely, increased hip adduction
strength is associated with increased disease progression and severity in the
knee (Yamada et al., 2001) indicating that perhaps this muscle group should not
be subject to strengthening exercises in persons with OA.
Although lower extremity muscle strengthening is beneficial in most
persons with OA, the benefits of simply improving strength may be compromised
by the enhanced quadriceps strength which in itself has been associated with
increased disease progression in persons with malaligned or lax knees (Sharma
40

et al., 2003). Thus a careful screening of patients prior to strengthening exercise
and appropriate modification of exercises is recommended to prevent joint
trauma as a result of malalignment or laxity.
While some studies have been conducted to determine the most
efficacious type of resistance training (isometric, isotonic, isokinetic), this area is
still largely unstudied (Eyigor et al., 2004; Gur et al., 2002; Topp et al., 2002). In
addition, evidence does not exist regarding the most appropriate load at which to
perform resistance exercise in order to get the best gains for persons with OA.

Water-Based Exercise
Studies comparing water-based exercise to land-based exercise find
functional gains achieved with both interventions. However, persons in the waterbased program had better improvement in pain (Cochrane et al., 2005), walking
distance and physical component on SF-12 (Foley et al., 2003) and persons in
the land-based program had better improvements in strength, walking speed,
and self-efficacy (Foley et al., 2003).
Functional Exercise
Functional exercises include activities, such as getting up from a chair and
climbing stairs. If resistance is added to the activities, they are considered
resistance exercises as in the case where an individual wears a weighted belt or
vest while performing sit to stand or stair climbing. If the duration of the activity is
sustained, it is considered aerobic exercise, such as climbing a flight of stairs five
times.
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Their use has been found to significantly improve times for performing
activities of daily living, isokinetic quadriceps muscle strength, WOMAC scores,
stair climbing, walking time, (Diracoglu e al., 2005; Lin et al., 2005) and
proprioceptive sensation (Diracoglu e al., 2005).

Mode of Action of Exercise
Despite increasing consensus and evidence for exercise as an effective
intervention in OA progression, the underlying physiologic mechanisms have not
been determined. This is most likely due to the complex and pleiotropic effects of
such a therapy on the physiology of the organism.
A commonly held view is that exercise improves joint biomechanics by
restoring muscular balance and strengthening supporting structures around the
joint, resulting in diminished stress and structural trauma to the cartilage. In vivo
biomechanical studies showed that exercise might influence the integrity of
muscle tissue. Thus, muscular balance and strengthening has been shown to
diminish stress and structural trauma to the soft tissues (Hootman et al., 2004;
Slemenda et al., 1998).
In vitro studies using tissue explants and isolated cells have revealed
mechano-sensitive pathways, such as mitogen activated protein kinase and gene
expression pathways for both degenerative and reparative actions of
chondrocytes (Fitzgerald et al., 2006; Lee et al., 2005; Sah et al., 1989). In vitro
studies of mechanical strain on chondrocytes show that low magnitude
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mechanical strain on cartilage suppresses IL-1 and TNF alpha (both proinflammatory cytokines) and up regulates proteoglycan and collagen synthesis.
However, high magnitude mechanical strain on cartilage is pro-inflammatory,
initiating cartilage destruction and inhibiting matrix synthesis. (Deschner et al.,
2003) This suggests a dose-response relationship between exercise and
collagen synthesis in humans as well. However, what constitutes low magnitude
and high magnitude mechanical strain with exercise is not clear, nor is the
difference in response in humans with shear forces alone versus compressive
forces alone versus a combination of forces.
The extent to which these are mechanistically related to events in the
whole joint and in combination with soluble mediators (cytokines and growth
factors) remains to be fully defined. Moreover, it is not entirely understood how
the complex function of joint movement translates into specific types of
biophysical signals such as compression, shear, fluid flow and streaming
potentials (Fitzgerald et al., 2006; Gray et al., 1989; Kerin et al., 2002; Kim et al.,
1995; Lee et al., 2005; Sah et al., 1989). The development of a simplified in vivo
animal model of mechanical overuse and detailed cell and biochemical
examination of the ensuing cartilage and bone response will aid greatly to this
area of research.
The availability of high resolution imaging on tissue structures, such as
delayed gadolinium-enhanced magnetic resonance imaging of cartilage
(dGEMRIC), an in vivo technique that relies on the principle of the negatively
charged contrast agent distributing inversely to the negatively charged
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glycosaminoglycans (GAGs) in the cartilage shows promising approaches to
evaluate the effect of exercise on structural and biochemical changes in joint
tissues such as cartilage (Link et al., 2006; Roos and Dahlberg, 2005; Tiderius et
al., 2004). Roos et al. utilized dGEMRIC to investigate the effect of moderate
exercise on knee cartilage quality and found that performing aerobic and weight
bearing strengthening exercises three times a week for 4 months resulted in a
significant improvement in cartilage quality as demonstrated by increased GAG
content. This correlated with change in the Knee Osteoarthritis Outcomes Survey
(KOOS) indicating an improvement in clinical status as well (Roos et al., 2005).
Physical exercise may also affect inflammation and the immune
response. A study of 274 persons with knee OA participating in an exercise and
nutrition program looked at serum levels of inflammatory markers including IL-6,
CRP, TNF-α, and the soluble receptors (sR) IL-6sR, IL-2sR, TNF-sR1 and TNFsR2. Higher serum levels of TNF-sR1 and TNF-sR2 (soluble receptors for a proinflammatory cytokine) were associated with lower physical function (Penninx et
al., 2004). Further, these persons had more pain and stiffness and more reported
physical disability as well as slower walking speeds and worse radiographic
scores.
Isometric exercises may induce a beneficial inflammatory response in the
joint tissue. For example, studies have shown that isometric exercises result in
increased molecular weight of hyaluronan, increased viscosity of joint fluid, and
decreased chondroitin sulfate concentration (Miyaguchi et al., 2003). Further, a
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rise in serum HA, a marker of acute inflammation (Elliott et al., 2005), was noted
with physical activity in persons with OA (Criscione et al., 2005).
Cell Based Therapies
Cartilage lesions have little capacity to spontaneously heal (Buckwalter
and Mankin, 1997). As a result, cell-based approaches have been developed to
assist in repairing cartilage defects. With these approaches, cells are
manipulated in vitro then implanted in the cartilage defect (Richter, 2007).
Mesenchymal stem cells have been used for this purpose because they can be
expanded by in vitro culture and still maintain their multilineage potential (DeBari,
2006). Cartilage cells from autologous cartilage elsewhere in the body have also
been removed, cultured, then implanted into the damaged area (Brittberg et al.,
1994). This type of therapy may be enhanced by use of resorbable biomaterials
for scaffolds into which chondrocytes are seeded and cultured, prior to
implantation (Marlovits, et al., 2006). These methods have undergone extensive
pre-clinical investigations using animal models of cartilage disease and defect,
but are now being used in humans.

Surgical Interventions
Surgical interventions are generally implemented only after conservative
measures have been unsuccessful (See Figure 2, Dieppe and Lohmander,
2005). They include both joint preserving (arthroscopy and osteotomy) and joint
replacement techniques.
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A commonly utilized surgical procedure for mild to moderate OA is
arthroscopy. This technique can range from simple lavage and debridement to
cartilage defect repair attempts and cartilage transplantation. Effectiveness of
arthroscopic intervention is controversial (Chang et al., 1993; Gross et al., 1991;
McEldowney and Weeker, 1995; McLaren et al., 1991; Moseley et al., 2002). If
OA is contained to one side of the joint, a correction osteotomy is an option in
order to transfer load-bearing from the affected to the non-affected region of the
knee. A Cochrane review of 13 studies involving 693 persons concluded that
osteotomy improves knee function and pain, but there is no evidence to support
that osteotomy is more effective than conservative treatment (Brouwer et al.,
2007).
Joint replacement techniques remove the pathological tissues and replace
them with prostheses. While there are no randomized controlled trials comparing
joint replacement to sham treatment or standard care, there are individual studies
on sham interventions demonstrating a moderate effect on pain (Hrobjartsson
and Gotzsche, 2001) and studies of joint replacement demonstrating a large
effect on pain (Ashworth et al., 2002; Fortin et al., 2002).
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Animal Model Research
Overview of Animal Models
Mechanistic studies of human disease progression and therapeutic
efficacies have utilized animal models since the 1950s. Human OA is generally
not diagnosed until it has progressed with pronounced pathological alterations in
the joint leading to pain and radiographic changes. Further, obtaining diseased
tissue prior to end-stage joint replacement surgery without potentially damaging
the joint is not possible, and non-invasive methods of assessing changes in joint
structure (i.e., MRI, radiographs) do not provide enough information on cellular
and metabolic dynamics in the diseased joint. For these reasons, animal models
of OA have been developed to provide a known cause of induction and time
points of disease progression (Bendele, 2001).
Since injury is a common predisposing factor, most models involve
surgically-induced insults in order to cause mechanical stress to the joint. Models
have been developed in sheep (Cake et al., 2004), dogs (Mastberger et al.,
2006), rabbits (Inouye et al., 1973), guinea pigs (Bendele et al., 1991), rats
(Hayami et al., 2006; Laurent et al., 2006; Moore et al., 2005), and mice
(Bendele, 2001). Direct comparison with age-matched, healthy tissue taken from
animals of the same or similar genetic and environmental backgrounds can be
readily obtained for radiographic, histologic, and biochemical evaluation
methods. More recently murine (mouse) models have gained popularity with
benefits of lower cost, homogeneity of genetic background, ability to inbreed, and
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the capacity to obtain an increasing number of genetically modified strains.
Creating surgically-induced injuries in mice has been difficult due to the small
size of the joints and therefore requires microsurgical techniques (Kamekura et
al., 2005).
Murine Models
Spontaneous OA
Age-onset development of OA occurs in STR, DBA/1, and C57 Black
mouse strains. These “spontaneous” models may reveal mechanisms that
underlie some forms of human OA (Yamamoto et al., 2005).
The highest incidence of this type of OA occurs in the STR/1N strain (Jay,
1951) and the related STR/ort strain (Sokoloff and Jay, 1956). Cartilage lesions
are detected histologically as early as 8 weeks of age and appear at the insertion
of the medial collateral ligament and the medial tibial plateau (Mason et al.,
2001). Males have a higher incidence than females, and cartilage loss is most
prevalent in the medial compartments of the knee joint. Interestingly,
spontaneous obesity develops at three months of age in these mice, even when
kept on a standard diet. Peak bone mass is reached at 12 weeks compared to 16
to 24 weeks in non-affected strains.
Other investigators using this mouse strain have reported high incidence
of patella subluxation (Walton, 1979), decreased anterior cruciate ligament
strength, soft tissue calcification (Evans et al., 1994) and increased biochemical
turnover of collagen in cartilage (measured by gel zymography) all of which may
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contribute to the spontaneous OA-like pathologies in these mice (AndersonMackenzie et al., 1999).
Histological evaluation of knee joints from STR/ort strain using TUNEL
assays showed an increasing number of apoptotic cells in cartilage covering
medial tibial and femoral bone with advanced histological lesions (Mistry et al.,
2004). This finding may be consistent with preceding biomechanical or metabolic
stress on the cartilage (Mason et al., 2001). In addition, cartilage of STR/ort mice
has been reported to be deficient in extracellular superoxide dismutase, a
reactive oxygen species (ROS) scavenger (Regan et al., 2005). This may
predispose to oxidative damage to cells and accelerated apoptosis.
C57 Black mice are also susceptible to developing OA lesions in knee
joints as a result of a genetic mutation with recessive Mendelian inheritance
(Silberberg and Silberberg, 1960). Incidence and severity of OA based on
histopathological cartilage damage assessed by hematoxyllin and eosin stain
and decreased toludine blue staining (Yamamoto et al., 2005) increases with age
in both males and females from 20% at 2 months to 80% at 16 months Cartilage
erosion appeared in the subchondral layers of cartilage Decreased collagen
content and fibril alignment as well as decreased proteoglycan contents
accompanied the cartilage destruction (Yamamoto et al., 2005).
The development of OA at relatively predictable time points would render
these “spontaneous” models appropriate for the evaluation of therapeutic
interventions for disease progression. However, they have not been widely used
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mainly due to the need to house and maintain these animals for up to a year
which increases the cost of experimentation.

Surgically-Induced OA
Post-trauma models of OA models are typically induced surgically to
create joint instability and have been applied in large animals, such as sheep
(Cake et al., 2004), dogs (Mastberger et al., 2006), rabbits (Inouye et al., 1973),
guinea pigs (Bendele et al., 1991), and rats (Hayami et al., 2006; Laurent et al.,
2006; Moore et al., 2005). The mouse presents a challenge for surgically-induced
OA because of its small size (Figure 9a) However, microsurgical techniques for
meniscal and ligament destabilizations have been successfully utilized to induce
OA-like joint changes in the knee (Kamekura et al., 2005). MCL transection
and/or complete or partial meniscectomy are the most commonly used
techniques, but other ligaments including the PCL, LCL, or ACL have also been
transected (Kamekura et al., 2005). For example, MCL transection and partial
medial menisectomy lead to development of mild cartilage lesions (fibrillations
and loss of superficial flattened cell layer) on the medial plateau in ~50% of
treated mice by 2 weeks post surgery, and by 3-4 weeks all mice with this injury
had developed OA-like changes (Clements et al., 2003).
The various surgical procedures are now typically classified on the
severity and direction of instability: a) severe, after transection of all ligaments,
including the patellar ligament, and removal of both menisci; b) moderate, after
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ACL transection and medial menisectomy; c) mild, after ACL transaction; and d)
medial, after MCL transection and medial menisectomy (Kamekura et al., 2005).
While many of these changes may be consistent with joint changes seen in
humans after ligament and/or meniscal injury, the medial model most closely
resembles changes seen in the majority of persons with OA. However, the
severe, moderate, and mild models may be helpful in investigating the
development and progression of certain subtypes of OA.
Surgical models have been widely used by the pharmaceutical industry for
pre-clinical studies on disease modifying OA drug development because of the
rapid, reproducible changes that result. However, several limitations need to be
considered. Firstly, OA is not always the result of significant trauma to the joint.
While some patients with OA can pinpoint specific injuries in which ligaments or
menisci were injured, many cannot. Hence OA may often be the result of
cumulative microtrauma which is not well represented by surgically-induced
models. Secondly, in surgically-induced models, cartilage damage occurs in a
relatively short time (1-2 weeks post surgery), whereas progression of human OA
occurs over the course of years. In addition, when humans sustain such joint
injuries it is rare for them to continue loading the joint. Most undergo surgical
repair in an attempt to restore joint stability. In instances where stability cannot
be successfully restored, activity is severely limited and therefore, joint loading is
minimized. Thirdly, surgical models have only limited use for evaluation of
therapies because the amount of trauma induced in the absence of surgical
repair does not allow “normal” joint loading and leads to continued joint damage
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even in the presence of interventions. Fourthly, surgeries can easily result in
direct damage to other joint structures, such as synovium and cartilage, at the
time of surgery that may initiate additional wound healing pathways (including
scarring) that are not normally part of the human OA pathology. Fifthly, the
biomechanics of joint loading in the mouse is quite different from that in the
human and may not provide accurate information regarding the effects of joint
instability.

Manipulation of Cartilage Specific Genes
Genetic models provide insight into possible causative factors and
generate strains that consistently develop OA (Clements et al., 2003; de Hooge
et al., 2005; Giancotti and Rusoslahti, 1999; Saamanen et al., 2000; Xu et al.,
2003; Zemmyo et al., 2003). Mutations known to make humans susceptible to
OA involve collagens II (Vikkula et al., 1994), IX (Olsen, 1997), and XI (Jacenko
and Olsen, 1995). As a result, many of the genetic models focus around these
candidate genes.
Spontaneous single nucleotide deletion in the ColXIa1 gene (α 1 chain of
type XI collagen) in the cho/+ strain results in thickened collagen fibrils in the
cartilage (Xu et al., 2003) and leads to destruction of cartilage and biochemical
alterations, such as increased chondrocyte metabolism and increased
proteoglycan degradation, similar to human OA (Tetlow et al., 2001).
Del 1 (+/-) strain has a deletion mutation in the transgene coding for type II
collagen (Saamanen et al., 2000). These mice produce shortened pro-alpha 1
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chains of collagen II and develop superficial fibrillation of cartilage at 12 weeks of
age. This progresses to cartilage erosion, meniscal degeneration, bony sclerosis,
and exposure of subchondral bone (Saamanen et al., 2007).
Deletion of an alpha 1 integrin, a transmembrane protein that binds
components of the extracellular matrix and may be involved in cell activation,
differentiation, proliferation, and survival (Giancotti and Rusoslahti, 1999) results
in synovial hyperplasia, increased cellularity and apoptotic cells in the cartilage,
and finally severe cartilage degeneration (Zemmyo et al., 2003).
The primary benefit of the genetic models is the known molecular etiology
and the controlled severity and incidence of OA pathogenesis. However,
limitations exist. These mice can be very difficult to breed and may need
specialized housing, both increasing the cost of experiment. Further, it is not
known if the gene is directly involved in OA or whether developmental changes
due to the deletion predisposes an individual animal to OA. For example, many
of these models develop skeletal deformations such as chondroplasias. These
models are not readily amenable to treatment interventions unless conditional
knock-outs are generated that display the gene abnormality only during
adulthood or upon induction of the disease. In addition disease progression may
not always mimic that which occurs in human disease because of a more
selective activation of pathogenetic pathways by genetic alterations and limited
representation of the many facets of OA development and progression (Figure 1)
may result.
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Chemical
OA-like changes can also be induced in joints by injection of noxious
agents such as, quinolone antibiotics (Christ et al., 1988), iodoacetate
(Guingamp et al., 1997; Janusz et al., 2001), collagenase (Blom et al., 2004) and
pro-inflammatory agents such as TGF-β1(Van Beuningen et al., 2000).
Quinolone, an antibiotic that targets bacterial topoisomerase, causes
articular cartilage degeneration in juvenile animals. These changes occur rapidly
(within 24 hours) and include focal swelling, chondrocyte death, and blister-like
lesions in the mid zone cartilage (Bendele, 2001). With time the cartilage
surrounding these lesions also deteriorates, with fibrillation and proteoglycan loss
similar to that seen in other models of OA (Bendele, 2001). While this model has
been used in guinea pigs (Bendele et al., 1990) and dogs (Gough et al., 1992), it
is rarely used because it affects only growth cartilage, but not articular cartilage,
and its mechanism is not well understood (Simonin et al., 1999).
Bacterial collagenase induces osteophyte development at the periarticular
margins followed by fibrosis and an influx of macrophages into the synovial
lining. This model is representative of some of the early changes seen within OA,
but does not reflect pathology seen in late stages of OA other than osteophyte
formation (Blom et al., 2004).
Iodoacetate causes cartilage thinning and fibrillation (Janusz et al., 2001)
as well as osteophyte development (Guingamp et al., 1997), but also produces
hyperalgesia and allodynia within one week of injection (Fernihough et al., 2004).
Because of the pain presentation, this method is primarily used to study pain.
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The pain symptoms produced can be controlled by oral administration of
Naproxen, rofecoxib, and acetaminophen which are also used for pain relief in
persons with OA (Bove et al., 2003).
Intra-articular injections of TGF-β1, a multifunctional modifier of skeletal
tissue growth (Heino et al., 2002; Yan et al., 2001), was first reported by Van
Beuningan et al. to induce OA-like changes in mouse knees. After multiple (up to
three) injections into the knee joint on alternate days, they reported osteophyte
formation (Van Beuningen et al., 2000) and influx of macrophage-like cells in the
synovial lining, which are important producers of cytokines and growth factors
regulating mesenchymal cell activities (Rappolee and Werb, 1992). Recent
studies using this model investigated the role of macrophages in osteophyte
formation (van Lent et al., 2004) and the role of interleukin-1 in OA development
(Blamey Davidson et al., 2005).
The primary benefit of this model is that OA-like changes can be initiated
within the joint in a very short period of time (less than a week in some
instances). Joint anatomy is maintained making it highly suitable to evaluating
therapeutic intervention effects.
As is the case for the surgical models, the injection models require
specialized, technical expertise to perform the targeted injections. The injection
(needle) may damage tissues within the joint cavity leading to additional injury
responses and substances may not be quantitatively delivered to the joint space.
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Animal Models and Therapeutic Hyaluronan Injections
The effects of intra-articular injections of HA on OA have not been well
studied in mice. However, some work has been done in this area on other animal
models. Rabbits receiving five weekly HA injections one month after anterior
cruciate ligament transection to induce OA demonstrated less severe cartilage
damage than the non-HA injected controls (Amyl et al., 2003; Takahashi et al.,
1999). In addition, a down-regulation of proteolysis enzymes such as MMP-3 and
cytokines, such as IL-1β in the synovium was reported (Takahashi et al., 1999).
This process appears to be partially mediated by CD44, a cell surface receptor
for HA (Waddell et al., 2007). In another report, rabbits with anterior cruciate
ligament transection that had five or ten weekly HA injections showed less
disease progression. This could be improved by increasing the therapy to ten
weekly injections (Amyl et al., 2003).
After bilateral partial medial meniscectomies in rabbits, the application of
five weekly HA injections resulted in significantly lower nitric oxide production and
decreased cell apoptosis in the central region of the meniscus (Kobayashi et al.,
2002; Takahashi et al., 2000) as well as increased collagen remodeling in the
peripheral region (Sonada et al., 2000)

Animal Models and Treadmill Exercise
There are limited studies using aerobic exercise with mice (Table 1).
Although treadmill running has not been utilized in mice with OA it has been used
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in non-OA mouse models. In a study of the effect of short term moderate
exercise on tumor metastases C57Bl/6 mice ran for one hour a day for 6 days at
a speed of 36 meters per minute (Murphy et al., 2004). G93A transgenic mice
with a mutation causing the development of amyotrophic lateral sclerosis ran 3045 minutes per day three to five times a week for eight weeks at speeds of 15-37
cm per second (Mahoney et al., 2004). The same mouse strain was used to
demonstrate that regular exercise was associated with an increased lifespan
after running the mice 30 minutes per day, five days a week at a speed of 21 cm
per second for 10 weeks (Kirkinezos et al., 2003).
Lightfoot et al. studied aerobic capacity variations in ten inbred strains by
running mice at 36-72 cm per second until the mice were unable to continue
(Lightfoot et al., 2001). C57Bl mice ran an average of eight minutes on testing
which is significantly lower than four other strains and places them on the lower
end of the spectrum of aerobic capacities in the strains tested (Lightfoot et al.,
2001).
Massett and Berk also investigated exercise training response in six
inbred and hybrid mouse strains by running them at speeds of 25-32 cm per
minute one hour per day, five days per week for four weeks (Massett and Berk,
2005). Subsequently exercise performance was assessed by running at speeds
of 14-62 cm/sec until exhaustion. Endurance exercise performance of C57Bl
mice was similar to Balb/c but significantly lower than other strains with only
small improvements in endurance exercise performance (22-33% increase in
distance) occurring after four weeks of training (Massett and Berk, 2005).
57

Finally, critical running speed (the speed that can be sustained for 40-60
minutes) was studied in three mouse strains by running at 30-85 cm per second
until exhaustion (Billat et al., 2005). For C57Bl mice, critical speed was
determined to be 20 cm per sec.
Maximum aerobic speed has been determined for mice and although it
has been shown to vary slightly between mouse strains (Billat et al., 2005;
Massett and Berk, 2005) it can be used to determine maximum oxygen uptake
(vO2 max), the maximum capacity to transport and utilize oxygen during
incremental exercise (Baker and Gleeson, 1999). A percentage of vO2 max is the
best method utilized in prescribing exercise with 40-60% vO2 max coinciding with
low intensity, 60-80% coinciding with moderate intensity, and greater than 80%
coinciding with high intensity (Swain et al., 2004). Using the formula vO2 = 3.99 +
1.94v where v is the speed, low intensity aerobic exercise for the mouse at 50%
vO2 is achieved at approximately 14 cm/sec (Baker and Gleeson, 1999).
The effect of treadmill exercise on OA in mouse models has not been
studied. Only voluntary wheel running in normal and collagen IIa1 knockout mice
was reported (Lapvetalainen et al., 2002). Running did not affect OA
development in normal mice but reduced incidence of spontaneous OA in the
knockouts (Lapvetalainen et al., 2002).
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Table 1: Studies investigating the effects of aerobic exercise in mice
Study

Strain

Mode of
Exercise
Voluntary
wheel
running
Treadmill
running
Treadmill
running

Effect
Investigated
OA
development

Outcome

Lapvetalainen et
al., 2002

Col 2a1
KO

Murphy et al.,
2004
Mahoney et al.,
2004

C57Bl/6

Lung tumor
metastases
ALS onset and
survival with
high intensity
endurance
training

G93A

Treadmill
running

Lightfoot et al.,
2001

10
strains of
inbred
mice

Treadmill
running

ALS lifespan
with moderate
intensity
endurance
training
Interstrain
variation
in aerobic
capacity

Decreased
metastases
No affect on onset
of symptoms;
faster decrease in
motor
performance and
death in male
mice only
Increased
lifespan; males
greater than
females

Kirkinezos et al.,
2003

Massett and
Berk, 2005

C57Black Treadmill
running

G93A

Billat et al., 2005 C57Black Treadmill
running

Exercise
training
response
Critical running
speed

Reduced OA
development

Strong genetic
contribution to
aerobic capacity
in mice—Balb/c
mice had 3 times
greater aerobic
capacity than
C57/Bl6 mice
22-33% increase
in distance after 4
weeks of training
Critical running
speed is 20
cm/sec;
v0 max is
2

approximately 8.0
ml O /g·h
2
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Chapter Two
Specific Aims and Research Hypotheses
OA is a debilitating condition affecting over 21 million persons in the
United States. This number is expected to rise in the coming decades. Current
treatment approaches for OA focus on symptom modifying measures (i.e., pain
relief) as disease modifying interventions do not currently exist. However, some
of the interventions used to relieve and improve the symptoms of OA may
actually have disease-modifying benefits. Two such non-surgical interventions for
OA are intra-articular HA injections and exercise.
In order to effectively study the mechanistic aspects of such treatment
options, an animal model of OA that is amenable for studying such intervention
outcomes is needed. Mouse models of OA have become increasingly popular
tools for this type of research due to rapidity, ease of disease assessment, costeffectiveness, and availability of targeted gene knock-in and knock-out strains.
The overall aims of this dissertation project were to: a) develop a rapidly
progressing mouse model of knee OA that does not need surgical intervention or
noxious chemical agents; and, b) test the response of the model to diseasemodifying interventions such as HA injections or exercise. The data obtained
from this study will provide novel information to refine and implement such
interventions in studies using larger animals and human patients. They can also
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be incorporated into educational materials for patient education in psychosocial
and physical therapy interventions.

Research Hypotheses
1. Comprehensive OA-like changes in murine knee joints (synovitis, soft tissue
fibrosis, osteophyte formation and cartilage and meniscus degeneration) can
be induced by anabolic stimulation of joint tissues by intra-articular TGF-β1
followed by mechanical overuse of the activated joint.
2. Cartilage degeneration in the above model can be inhibited by therapeutic
intervention during the anabolic stimulation phase, using intra-articular HA
injections.
3. Cartilage degeneration in the above model can be decreased by four weeks of
alternate day, low intensity aerobic exercise preceding the anabolic
stimulation phase.

Specific Aims
The research was conducted under three specific aims:
Aim 1. Develop and characterize a progressive non-surgical model of knee OA
in adult mice. C57Bl/10 male mice were subjected to two alternate day intraarticular injections of TGF-β1 into one knee joint, followed by high intensity
treadmill running at 32 cm/sec for 13 days. Joint pathology was evaluated by
radiographs, India ink cartilage grading, and histopathology. The validity of the
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OA model was established by demonstrating resistance of ADAMTS 5-/- mice to
cartilage degeneration.
Aim 2. Examine the capacity of intra-articular HA injection to inhibit progression
of knee joint degeneration in the mouse model established under Specific Aim 1.
High molecular weight HA (SupartzTM, Clinical Grade) was injected intraarticularly during the anabolic /inflammatory phase of the model. Metabolic
turnover routes of injected HA in the joint were examined by in vivo imaging of
fluorescently labeled HA in the knee joint and by quantitative ELISA of HA in
plasma. Joint pathology was evaluated by radiographs, India ink cartilage
grading, and histopathology.
Aim 3. Examine the capacity of low intensity aerobic exercise to prevent onset
and progression of joint degeneration in the mouse model established under
Specific Aim 1. C57Bl/10 male mice underwent four weeks of alternate day, low
intensity treadmill running at 14 cm/sec prior to inducing OA by TGF-β1 injection
and mechanical overuse through high intensity treadmill running. Joint pathology
was evaluated by radiographs and India ink cartilage grading.
Each specific aim and corresponding research hypothesis will be
addressed in separate chapters following. The research design, materials,
methods, results and analyses, and discussion and conclusions for the
development of the model will be presented in chapter 3, the HA intervention in
chapter 4, and the aerobic exercise intervention in chapter 5.
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Chapter Three
Development of Mouse Model of Knee OA

All in vivo experimental protocols described below have been approved by
the IACUC of Rush University, Medical Center, under Protocol 07-009.

Research Design (Figure 8 and Table 2)
Experimental groups :
1.1 Cage Control Day 5 (n=14): no TGF-β1 injections, cage activity,
sacrificed day 5
2.1 Cage + TGF-β1 Day 5 (n=19): TGF-β1injections, cage activity,
sacrificed day 5
3.1 Cage + Sham Day 5 (n=19): BSA injections in lieu of TGF-β1
injections, cage activity, sacrificed day 5
4.1 Cage Control Day 18 (n=18): no TGF-β1 injections, cage activity,
sacrificed day 18
5.1 Cage + TGF-β1 Day 18 (n=23): TGF-β1 injections, cage activity,
sacrificed day 18
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Figure 8: Research design for the development of a non-surgical mouse model of
OA

Day 1
Day 3
TGF-β1Injection Right Leg
(2x 48 h interval)

Cage
Day 5

A

Day 18

Sacrifice

Day 1
Day 3
TGF-β1 Injection Right Leg
(2x 48 h interval)

Sacrifice

Mechanical Overuse
Day 5
Day 18

B

Overusethrough high intensitytreadmill running
•Speed= 32 cm/sec
•Duration = 20 minutes
•Frequency= dailyx13 days
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Sacrifice

6.1 Cage + Sham Day 18 (n=19): BSA injections in lieu of TGF-β1
injections, cage activity, sacrificed day 18
7.1 Mechanical Overuse Day 18 (n=20): no TGF-β1 injections,
mechanical overuse via high intensity treadmill running, sacrificed
day 18
8.1 Mechanical Overuse + TGF-β1 Day 18 (n=19): TGF-β1 injections,
mechanical overuse via high intensity treadmill running, sacrificed
day 18
9.1 Mechanical Overuse + Sham Day 18 (n=18): BSA injections in lieu of
TGF-β1 injections, mechanical overuse via high intensity treadmill
running, sacrificed day 18
In addition to C57Bl/10 mice, 129SvEvBrd Agg 2-/- mice (ADAMTS-5
Knockouts) and their controls (129S6/SvEvTac ) were used to determine if
ADAMTS-5 plays a role in the cartilage changes. Only males 12-16 weeks of age
were used.
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Table 2: Mouse utilization for the induction of OA-like changes
Strain

C57Bl/10
Agg 2-/n=169
n=36
Evaluation H/E India ink H/E India ink
and FACE
and FACE
8
6
2
0

Cage Control
Day 5
Cage + TGF-β1
Day 5
Cage + Sham
Day 5
Cage Control
Day 18
Cage + TGF-β1
Day 18
Cage + Sham
Day 18
Mechanical Overuse
Day 18
Mechanical Overuse + TGF-β1
Day 18
Mechanical Overuse + Sham
Day 18

129S6/SvEv
n=42
H/E
India ink
and FACE
2
0

13

6

2

0

2

0

13

6

0

0

0

0

12

6

2

6

3

6

17

6

2

6

3

6

13

6

0

0

0

0

14

6

2

6

4

6

13

6

2

6

4

6

12

6

0

0

0

0
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Materials
TGF-β1 (PeproTech, Inc., Rocky Hill NJ); Bovine Serum Albumin (Sigma
Aldrich, St. Louis MO); India ink (Speedball Arts Product Co., Statesville NC);
ketamine (Phoenix Pharmaceutical Inc., St. Joseph MO); xylazine (Phoenix
Pharmaceutical Inc., St. Joseph MO); injection needles (Tyco Healthcare Group,
Mansfield MA); 5 mm and 3 mm micro dissection spring scissors (Roboz Surgical
Instrument Co. Inc., Gaithersburg MD); Human TGF-β1 ELISA kit (Bender Med
Systems, Burlingame CA); eppendorf tubes (DOT Scientific, Inc., Burton MI);
heparin (Becton Dickinson Vacutainer Systems, Rutherford NJ); hematoxylin
(Richard Allan Scientific, Kalamazoo MI); eosin (Richard Allan Scientific,
Kalamazoo MI); HA ELISA materials were obtained and prepared as described
(Li et al., 1989; Rayan et al., 1998; Thonar et al., 1992); FACE chemicals were
obtained and prepared as described (Plaas et al., 2001).
General purpose, two-lane mouse treadmill with single belt construction
and dividing wall outfitted with an electrical stimulus system composed of two
shock grids with stimulus intensity (163 V at a range of 0-1.5 mA, for a max of 0.5
seconds per shock) and monitored by LED lamps to indicate which stimulus grid
is active (Stoelting, Inc., Wood Dale IL). The manufacturer’s design of the
electrical stimulus grid reflects special attention to avoid injuries to animals.
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Methods
Mouse Breeding and Husbandry
The following strains of mice were used for experimentation: C57Bl/10
male mice procured from Jackson Laboratories or National Cancer Institute at 711 weeks of age and housed until they were 12 weeks old; 129S6/SvEvTac
breeding pairs from Taconic; 129SvEvBrd Agg 2-/- (ADAMTS 5-/- exon 2 back
crossed into the C57B./6 strain) breeding pairs obtained from Charles River
Laboratories through Dr. Micky Tortorella and Dr. Anne-Marie Malfait (Pfizer,
Inc.). Twelve week old 129S6/SvEvTac and 129SvEvBrd Agg 2-/- (ADAMTS 5-/-)
mice used for experiments were obtained through an in-house breeding program.
All mice were housed in polycarbonate shoebox rodent cage (five mice per cage)
with corncob pelleted bedding and were given free access to food (Harlan
Tekland Global Protein Rodent Diet) via wire bar lid and acidified water via water
bottle and/or automated watering system. Animals were monitored for health on
a daily basis and received cage changes every two weeks. For procedures
requiring restraint, mice were held by the scruff of the neck with thumb and
forefinger and the tail was secured between the fourth and fifth fingers. Intraarticular injections and blood collections were performed under general
anesthesia consisted of a ketamine/xylazine cocktail (100mg/kg ketamine + 10
mg/kg xylazine) in sterile PBS delivered intraperitoneally via a 28G x ½ inch
needle on 0.5 ml syringe. Upon termination of the protocol mice were humanely
euthanatized via carbon dioxide followed by cervical dislocation to confirm death.
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Intra-Articular TGF-β1 Injections
Twelve-week old adult male mice were anesthetized as described above,
right legs shaved with enough border to prevent fur from contaminating the
injection site and the knee joint area rinsed with dilute iodine solution. TGF-β1
(PeproTech, Inc., Rocky Hill, NJ) (200 ng in 6 µl of sterile PBS/0.1% purified
BSA) or 6 µl BSA solution alone was injected with a 28G x ½ inch needle through
the patellar ligament into intra-articular space of the knee joint (Figure 9).
Animals were allowed to recover and then transferred back to their home cage.
Injections were repeated after a 48 hour interval to achieve repeatedly high levels
of this factor in the joint.
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Figure 9: Site of needle entry for intra-articular injection of the knee between the
femur and tibia just below the patella through the patella ligament and into the
joint capsule. a) Mouse shown actual size; and b) right knee joint enlarged to
show a more detailed injection site
a)

b)
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Blood Collection and Plasma Preparation
Blood (5-7 drops for in vivo time points and terminal bleeds at time of
sacrifice) was collected from the submandibular vein at baseline using a sterile
18G needle, two days post first TGF-β1injection (day 3), two day post second
TGF-β1 injection (day 5), one week post second TGF-β1injection (day 12), and
14 days post second TGF- β injection (day 18). Prior to all blood draws
anesthesia was administered as described previously. Blood was collected into
heparinized, sterile Eppendorf tubes, cells removed by centrifugation at 13,000
rpm for ten minutes at room temperature, plasma supernatants removed and
stored at -80º C until further analyses.

TGF-β1 Enzyme Linked Immunosorbance Assay (ELISA)
Twelve-week old adult male mice were divided into control and treatment
groups. The treatment group (n = 6) received TGF-β1 injections as described
above. The control group (n =6) received intra-articular injections of BSA. Blood
was drawn daily and prepared as described previously. Mouse TGF-β1 ELISA
and human TGF-β1 ELISA was performed according to manufacturer’s directions
(Bender Med Systems, Burlingame CA).
ELISA detection of circulation human TGF-β1 in the mouse was negative
and consistent with the injected protein being utilized within the joint and/or
cleared by the lymphatic system. Interestingly, plasma levels of
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endogenous (mouse) TGF-β1 were elevated following each intra-articular TGFβ1 injection (Figure 10). In comparison, intra-articular injection of BSA resulted in
a temporary decrease in endogenous plasma TGF-β1.
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Figure 10: Endogenous (mouse) TGF-β1 concentrations for mice injected with
human TGF-β1 and mice injected with BSA as measured by mouse TGF-β1
ELISA and expressed as a percentage of predose. Each time point represents
two assays.
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Mechanical Overuse Through High Intensity Treadmill Running
Treadmill running was initiated one day after the second TGF-β1 injection
(Figure 11). The mice were familiarized with running on the treadmill for two days
at speeds of 24-32 cm per second for 20 minutes per day. Strenuous treadmill
running was started on day three and continued for 20 minutes per day for 13
days. Running speed was calculated as follows: using the formula vO2max = 3.99
+ 1.94v where v is the speed (km/hour) and vO2max for C57Bl mice is 8.0 ml
O2/g·hour, high intensity aerobic exercise for the mouse at approximately 80%
vO2 is achieved at a speed of 32 cm/second (Baker and Gleeson, 1999; Billat et
al, 2005).
A daily record was kept for each animal that included: duration of the run
(minutes), distance run (calculated from the run time and speed of the treadmill),
and number and time of interactions with the shock grid. In addition, treadmill
performance was measured by the amount of time each mouse stayed on the
front half of the running treadmill (Figure 11).
Mice readily adapted to the daily treadmill running. However, if an animal
refused to run continuously during the initial familiarization period, or up to 2
consecutive days during therapeutic exercise, it was excluded from further
studies. No signs of pain or distress even at the early inflammatory stage after
TGF-β1 injection were noted, excluding the need for analgesics.
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Figure 11: Mechanical overuse through high intensity treadmill running
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The C57Bl/10 mice ran 381.7 meters per day on average and the
129SvEvBrd Agg2-/- mice ran 379.2 meters per day on average. A difference was
noted between C57Bl/10 TGF-β1 injected and non-injected mice in the time
spent on the front half of the treadmill. Initially both groups spent an average of
19.5 minutes on the front half of the treadmill. The non-TGF-β1 injected mice
continued to spend an average of at least 18 minutes on the front half of the
treadmill throughout the 13 day period. However, by day 5 of running (day 9 of
the protocol) the TGF-β1 injected mice spent an average of 18 minutes or less,
and by day 17 they spent an average of 14.6 minutes. This difference between
TGF-β1 injected and non-injected mice was not apparent in the 129SvEvBrd
Agg2-/- (ADAMTS 5 KO) strain. However, the knockout mice did not run as well
as the C57Bl/10 mice. The 129SvEvBrd Agg2-/- (ADAMTS 5 KO) mice came in
contact with the shock panels more frequently and remained in contact with the
shock panels for longer periods of time. The most notable difference was in the
time spent on the front half of the treadmill. The C57Bl/10 mice ran on the front
half of the treadmill (away from the shock panel) an average of 19.5 minutes
while the 129SvEvBrd Agg2-/- (ADAMTS 5 KO) mice ran on the front half of the
treadmill an average of 0.7 minutes. In addition, the 129SvEvBrd Agg2-/(ADAMTS 5 KO) mice developed abrasions on their feet as a result frequent
contact with the shock panel. These abrasions were treated with silvadene
cream.
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Tissue Harvesting
Hind limbs were harvested from euthanatized animals for histopathological
evaluation via transection of the mid shaft of the femur. Fur, skin, and excess
muscle tissue was removed, limbs placed in saline soaked gauze, and stored at 20° C evaluation as below.

Radiography
Animals were sacrificed on day 5 and day 18 and placed on a transparent
platform with lower extremities in full knee extension in an anterior/posterior view
and in a 90º flexed position in a medial/lateral view. Radiographs of the lower
body were taken using the KODAK Molecular Image Station-In Vivo FX with
Kodak Molecular Imaging Software with settings of 60 second x-ray exposures,
no filters, f-stop 5.8, and a field of view of 40. Imaging allowed visualization of
osteophyte formation and bony alignment.

India Ink Cartilage Surface Evaluation
Animals were sacrificed on day 5 and day 18, hind limbs harvested as
described above, and tissues stored in saline soaked gauze at-20 degrees C.
Prior to India ink staining joints were dissected under a Nikon SMZ1000
microscope as follows: 1) the patella ligament was transected and diagonal cuts
along medial and lateral joint lines were made to allow the patella to be pulled
superiorly away from the joint; 2) medial and lateral collateral ligaments were
then transected allowing joint distraction and transection of the cruciate
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ligaments; 3) remaining joint capsule was cut to allow full separation of the tibia
and femur; 4) residual synovial tissue and menisci were removed from tibial
plateaus and femoral condyles to allow full exposure of the cartilage surfaces.
Cartilage surfaces were then rinsed with PBS and photographed with a Nikon
SMZ 1000 camera on a dissecting microscope and SPOT Basic software version
3.5.9 for Windows.
India ink was applied to femoral condyles and tibial plateaus with a small
brush and allowed to set for two minutes. Unbound ink was removed with saline
washes (up to 30 seconds) and gently dabbing with a cotton-tipped applicator.
Marked cartilage surfaces were re-photographed.
Images were viewed in Adobe Photoshop for scoring (Figure 12). Femoral
and tibial surfaces were divided into four quadrants each and cartilage damage
assessed in each quadrant by the following grading system (Kobayashi et al.,
2000).
0 = Grade 1 (intact surface): surface normal in appearance and does not
retain ink
1 = Grade 2 (minimal fibrillation): surface appeared normal before staining,
but the India ink showed fibrillation
2 = Grade 3 (overt erosion): surface fibrillation was apparent before staining
and areas retained ink as intense black patches
3 = Grade 4 (ulceration): loss of cartilage exposes underlying bone
Thus for each tibial or femoral surface a scoring range of 0-12 can be determined
with higher scores denoting increased cartilage damage.
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Cartilage scores for all four quadrants were analyzed individually then
summed to obtain the overall cartilage score for each cartilage surface (right
femur, left femur, right tibia, and left tibia). In addition, quadrants 1 and 2 were
summed for the anterior surface score, quadrants 3 and 4 for the posterior score.
Finally quadrants 1 and 3 were summed for the lateral cartilage score and
quadrants 2 and 4 for the medial cartilage score (Figure 13).
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Figure 12: Example grading of femoral and tibial cartilage surfaces after India ink
staining
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Figure 13: Cartilage surfaces were divided into four quadrants. Anterior cartilage
= quadrant 1 + quadrant 2; posterior cartilage = quadrant 3 + quadrant 4; lateral
cartilage = quadrant 1 + quadrant 3; medial cartilage = quadrant 2 + quadrant 4

.
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Hematoxyllin/Eosin Histopathology
Hind limbs were dissected at the mid-femur, skin and muscle were
removed prior to fixation in 10% neutral buffered formalin for 48 hours, and
specimens were decalcified for 2 weeks in 5% EDTA (in phosphate buffered
saline, pH 7.0), prior to processing and paraffin embedding as described (Plaas
et al., 2007). Sections (6 µm thin) were cut, stained with hematoxyllin and eosin
(H/E) using the following sequence of steps: two deparaffinization steps in xylene
(2 minutes each), rehydration through graded alcohols (100% for 2 minutes, 95%
for 2 minutes, DI water for 2 minutes), hematoxyllin for 5 minute washes (DI
water for 30 seconds, Scott solution for 30 seconds, DI water for 30 seconds, 1%
acid alcohol wash 15 seconds, 95% EtOH for 2 minutes), eosin for 5 minute
washes (95% EtOH for 2 minutes, 95% EtOH for 2 minutes, 100% EtOH for 2
minutes, 100% EtOH for 2 minutes), dehydrated through xylene and cover
slipped in mounting medium.
Stained sections were viewed with an Olympus BH-2 microscope, images
captured via a CCD camera, and analyzed by Adobe Photoshop software. This
method provides a view of the tissue morphology highlighting cellularity and
tissue types. Data were analyzed observationally and used for inter- and intragroup comparisons.
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Fluorophore-Assisted Carbohydrate Electrophoresis (FACE) Analyses
FACE is a sensitive, specific and rapid method for the detection of
carbohydrates including glycosaminoglycans (GAGs) such as chondroitin sulfate
and hyaluronan, both of which are abundant in cartilage tissue (Calabro et al.,
2001; Plaas et al., 2001) The amount of each saccharide in the starting mixture is
reflected by the fluorescence intensity of the resulting band on the gel (Plaas et
al., 2001). GAGs are synthesized as polymers of repeating disaccharides
covalently bound to core proteins to form proteoglycans. When GAG chains are
cleaved, a free reducing group that can be fluoro-tagged is created. These fluorotagged products are separated on polyacrylamide gels and fluorescent images
recorded by CCD camera (Calabro et al., 2001).
Tibial and femoral cartilages were removed at the epiphyseal junction and
GAGs solubilized by digestion for four hours at 60° C in 200 ul of 0.1 M sodium
acetate, pH 7.0 containing proteinase K. The digest was cleared by
centrifugation, the supernatant heated at 100° C for ten minutes to inactivate the
proteinase. Salt and peptides were removed from the GAGs by centrifugation on
MicroCon3 filters, and then digested with 5 mUnits of chondroitinase ABC in 200
ul of ammonium acetate pH 7.4 at 37 C for 18 hours. Buffer salts were removed
by speedvac evaporation, the dried disaccharide products derivatized with 2aminoacridone/cyanoborohydride separated by electrophoresis on 20%
polyacrylamide gels and fluorescent bands imaged and quantitated as described
(Plaas et al., 2001).
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Data Evaluation: Statistical Parameters
Statistical analyses were performed using Statistical Package for Social
Sciences (SPSS) version 15.0 for Windows. Data was analyzed for descriptive
statistics (means, medians, standard deviations) and fixed effect one way
analysis of variance (ANOVA) with Tukey post hoc testing and level of
significance at p value less than 0.05. Group comparisons were made for overall
cartilage scores, total scores for each cartilage surface (right femur, left femur,
right tibia, and left tibia), anterior, posterior, medial and lateral areas of each
cartilage surface, and each quadrant (anteromedial, anterolateral, posteromedial,
and posterolateral) on each cartilage surface. Power analysis based on the 4
point grading system and with the assumption based on preliminary studies of a
between group mean difference of at least one point revealed a sample size of 3
in control groups and 6 in treatment groups per time point sufficient for power
>80%.
In addition Repeated Measures ANOVA with Tukey post hoc testing and
level of significance at p value less than 0.05 was used to analyze data on
treadmill performance data. The time each mouse spent on the front half of the
treadmill each day was expressed as a percentage of the total time and data
were analyzed for descriptive statistics and differences within and between
groups and within and between days.
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Results and Analyses
Effect of TGF-β1 Injection and Mechanical Overuse on Bone Structure
Radiographic assessment of right knee joints in anterior/posterior and
medial/lateral views failed to detect any gross changes in bone remodeling with
TGF-β1 alone or in combination with mechanical overuse through high intensity
treadmill running (Figure 14). Furthermore, the mechanical overuse did not
result in generation of bone fractures that could contribute to the pathological
joint degeneration.
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Figure 14: Anterior/posterior and medial/lateral radiographs of right knees at day
18
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Anabolic Stimulation of Joint Tissues by Intra-articular Injection of TGF-β1
Transection of the anterior cruciate ligament in animal models is the most
commonly used injury that results in biochemical, biomechanical and
morphological changes in the articular cartilage, resembling OA pathogenesis in
the human knee. The joint pathologies in these models is comprised of an
anabolic (hypertrophic) phase followed by a catabolic (degenerative) phase
(Adams and Brandt, 1991, Adams, 1989; Adams et al., 1983). There is a
progressive increase in the amount of articular cartilage and meniscal tissue
hypertrophy in the unstable knee, indicative of an active synthetic response by
resident cells. This together with formation of osteophytes and capsular fibrosis
precedes the cartilage degeneration phase of the disease (Adams and Brandt,
1991, Adams, 1989; Adams et al., 1983).
Van Beunigen et al. reported similar pathologies in soft tissues of mouse
knee joints following multiple(4-6), consecutive intra-articular injections of TGFβ1 into murine knee joints (Van Beuningen et al., 2000). Similarly, we observed
that even after two consecutive injections of TGF-β1, extensive synovial
hyperplasia as well as meniscal and articular cartilage hypertrophy developed
(Figure 15). In particular, the synovial lining in naïve mice was about 1-3 cells
deep and cell densities were increased dramatically by TGF-β1. In addition,
cellular infiltration and granulation tissue formation in the subintimal layers of
injected knees was apparent.
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Figure 15: Histopathological evaluation of right knee medial compartments and
synovial lining for C57Bl/10 mice day 5 following H/E staining. (A) 4x
magnification of saggital sections (medial compartment); (B) 20 x (left hand
panels) and 40x (right hand panels) of synovial lining showing extensive
hyperplasia induced by TGF-β1. SF = synovial fluid; A = adipocyte (fat cell)
Cage Controls, and (b) Cage + TGF-β1 day 5
(A)

(B)
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SF

SF

SF

SF

Cage + TGF-β1

A

Hyperplasia
Hyperplasia
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Synovial Lining Fibrosis and Cartilage Degeneration at Two Weeks Post TGF-β1
Injection
Mice maintained for two weeks after the second TGF-β1 injection either at
cage activity or with mechanical overuse through high intensity treadmill running,
developed advanced OA pathologies, cartilage lesions, and osteophyte
development (Figure 16). Synovial hyperplasia was still present, but less
pronounced compared to acute TGF-β1 treatment. In addition, fibrosis developed
in the menisci [Figure 16 a (iv) and b (iv)] and femoral joint margins [Figure 16 b
(ii)]. These findings were not apparent in any of the control groups
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Figure 16: Histopathological evaluation of right knee medial compartments and
synovial lining for C57Bl/10 mice day 18 following H/E staining.
Cage +TGF-β1 Day 18:(a) 4x magnification, whole joint saggital section; (b) 20x
magnification cartilage degeneration on femoral condyle; (c) 20x magnification
cartilage degeneration on tibial plateau; (d) 20x magnification of medial meniscus
Mechanical overuse +TGF-β1 Day 18:(e) 4x magnification, whole joint saggital
section; (f) 20x magnification synovial fibrosis; (g) 20x magnification cartilage
degeneration on tibial plateau; (h) 20x magnification of medial meniscus
b
Cage + TGF-β1

Lesion

a

d
c

Mechanical
Overuse + TGF-β1

f

e
h

g
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India Ink Scoring of Cartilage Surfaces
In keeping with the histological evaluation, India ink staining after intraarticular injections of TGF-β1 followed by 14 days of cage activity or treadmill
running showed the development of cartilage degeneration (lesions and
fibrillation/fibrotic changes) on both the right femoral cartilage surfaces (Table 3)
and the right tibial cartilage surfaces (Table 4). For all 3 control groups (noninjected, BSA injected, cage, or treadmill running only) cartilage surfaces scored
<1. Minimal fibrillation was seen in some, but not all animals. By comparison, for
the group of mice that received intra-articular TGF-β1 and were maintained with
cage activity, scores on anterior surfaces only were significantly higher than for
the control group—posterior surfaces did not differ significantly (Figure 17). Mice
receiving TGF-β1 injections and mechanical overuse averaged scores of > 2.00
in all four quadrants on femurs and > 1.83 in all four quadrants on tibias.
These results confirm previously published data (Van Beunigen et al.,
2000) that cartilage fibrillation and erosion developed after prolonged
administration of intra-articular TGF-β1. Notably, exposure to treadmill running
after intra-articular TGF-β1 resulted in significantly more cartilage damage on all
anterior surfaces of femurs and tibias than cage activity after injection and gave
increased India ink scores in these regions (Figures 17-18).
Damage to cartilage surfaces in contralateral (left) legs after TGF-β1
injection was also noted at day 5 and day 18 with both cage activity and
mechanical overuse (Figures 19-21) and may indicate the involvement of
systemic or neuronal (pain) pathways during joint disease development.
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Table 3: Mean cartilage scores for right femurs by quadrant (standard deviations
in parentheses)

Cage Control
Day 5
Cage + Sham
Day 5
Cage + TGF-β1
Day 5
Cage Control
Day 18
Cage + Sham
Day 18
Cage + TGF-β1
Day 18
Mechanical Overuse
Day 18
Mechanical Overuse + Sham
Day 18
Mechanical Overuse + TGF-β1
Day 18

AnteroMedial
Quadrant
0.00
(0.00)
0.00
(0.00)
1.80*
(0.45)
0.00
(0.00)
0.00
(0.00)
2.00*
(0.89)
0.00
(0.00)
0.00
(0.00)
2.00*
(0.89)

AnteroLateral
Quadrant
0.67
(0.58)
0.50
(0.71)
1.40*
(0.55)
0.00
(0.00)
0.00
(0.00)
2.50***
(0.55)
0.00
(0.00)
0.00
(0.00)
2.50***
(0.55)

PosteroMedial
Quadrant
0.00
(0.00)
1.00
(0.00)
1.60
(0.55)
0.00
(0.00)
1.00
(0.00)
1.33
(0.52)
0.33
(0.58)
0.67
(0.58)
2.33*
(0.82)

PosteroLateral
Quadrant
0.67
(0.58)
1.00
(0.00)
1.80
(0.45)
0.67
(0.58)
1.50
(0.71)
2.00
(0.62)
1.00
(1.00)
0.67
(1.16)
2.67**
(0.52)

* denotes statistically significant difference from non-TGF-β injected groups at p<0.05;
** denotes statistically significant difference from non-TGF-β injected groups at p<0.01;
*** denotes statistically significant difference from non-TGF-β injected groups at p<0.005
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Table 4: Mean cartilage scores for right tibias by quadrant (standard deviations in
parentheses)

Cage Control
Day 5
Cage + Sham
Day 5
Cage + TGF-β1
Day 5
Cage Control
Day 18
Cage + Sham
Day 18
Cage + TGF-β1
Day 18
Mechanical Overuse
Day 18
Mechanical Overuse + Sham
Day 18
Mechanical Overuse + TGF-β1
Day 18

AnteroMedial
Quadrant
0.67
(0.58)
0.00
(0.00)
1.00
(0.71)
0.00
(0.00)
0.50
(0.71)
2.00*
(0.00)
0.00
(0.00)
0.00
(0.00)
2.33***
(0.52)

AnteroLateral
Quadrant
0.33
(0.58)
0.00
(0.00)
0.40
(0.55)
0.00
(0.00)
0.50
(0.71)
1.83**
(0.41)
0.00
(0.00)
0.00
(0.00)
2.33***
(0.52)

PosteroMedial
Quadrant
0.00
(0.00)
0.50
(0.71)
0.80
(0.45)
0.00
(0.00)
0.50
(0.71)
1.33
(0.82)
0.00
(0.00)
0.33
(0.58)
1.83**
(0.75)

PosteroLateral
Quadrant
0.00
(0.00)
0.00
(0.00)
1.00
(0.71)
0.00
(0.00)
0.00
(0.00)
1.33
(0.52)
0.33
(0.58)
0.67
(0.58)
2.50***
(0.55)

* denotes statistically significant difference from non-TGF-β injected groups at p<0.05;
** denotes statistically significant difference from non-TGF-β injected groups at p<0.01;
*** denotes statistically significant difference from non-TGF-β injected groups at p<0.005
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Figure 17: Mean cartilage scores for right femurs by quadrant. 1 = control; 2 =
+TGF-β1 injection; 3 = + sham injection: 0 depicts no cartilage damage
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* denotes statistically significant difference from non-TGF-β injected groups at p<0.05;
** denotes statistically significant difference from non-TGF-β injected groups at p<0.01;
*** denotes statistically significant difference from non-TGF-β injected groups at p<0.005
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Figure 18: Mean cartilage scores for right tibias by quadrant. 1 = control; 2 =
+TGF-β1 injection; 3 = + sham injection; 0 depicts no cartilage damage
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* denotes statistically significant difference from non-TGF-β injected groups at p<0.05;
** denotes statistically significant difference from non-TGF-β injected groups at p<0.01;
*** denotes statistically significant difference from non-TGF-β injected groups at p<0.005
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Figure 19: Mean cartilage scores for left femurs by quadrant. 1 = control; 2 =
+TGF-β1 injection; 3 = + sham injection; 0 depicts no cartilage damage
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** denotes statistically significant difference from non-TGF-β injected groups at p<0.01
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Figure 20: Mean cartilage scores for left tibias by quadrant. 1 = control; 2 = +TGFβ1 injection; 3 = + sham injection; 0 depicts no cartilage damage
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0

Figure 21: Mean cartilage scores by group for right and left knee cartilage
surfaces. 1 = control; 2 = +TGF-β1 injection; 3 = + sham injection: 0 depicts no
cartilage damage
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* denotes statistically significant difference from non-TGF-β injected groups at p<0.05;
** denotes statistically significant difference from non-TGF-β injected groups at p<0.005;
*** denotes statistically significant difference from non-TGF-β injected groups at p<0.0001
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FACE Analysis of Cartilage Chondroitin Sulfate Content
To confirm the usefulness of India ink scoring as a reliable means of
assessing loss of murine knee joint cartilage, the total chondroitin sulfate (CS)
contents of dissected femoral and tibial cartilages was determined using FACE
(Figure 22). Total chondroitin sulfate content was 6.7 + 1.2 µg per joint in naïve,
untreated animals. This was decreased to 5.6 + 1.5 µg per joint in TGF-β1
treated joints with cage activity and to 3.4 + 2.2 µg after TGF-β1 and mechanical
overuse. Mechanical overuse alone for 14 days showed a slight increase in CS
content per joint to 8.2 + 1.8 µg compared with untreated cage control joints.
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Figure 22: Chondroitin Sulfate content of right knee cartilage as determined by
FACE analyses

100

Effect of TGF-β1 Injections and Mechanical Overuse on ADAMTS-5 KO Mice
Cartilage degeneration in surgically induced models of OA is dependent
on the activity of ADAMTS 5 protease in joint tissue. To determine if such a
mechanism also operates in the progression of cartilage damage observed in this
model, ADAMTS 5 KO mice underwent TGF-β1 injection and mechanical
overuse through high intensity treadmill running. Knockout mice showed no
damage to either tibial plateau or femoral condyle cartilage when injected with
TGF-β1 without or with subsequent mechanical overuse. Thus, India ink scores
remained low, similar to those in naïve wildtype mice. Histological assessment
confirmed lack of cartilage degeneration as well as synovial fibrosis (Figure 23).
However, synovial hyperplasia was present as seen with the C57Bl/10 mice at
day 5 (Figure 23).
Treadmill Performance
While both the number of shocks encountered during the daily run and the
amount of time spent on the front half of the treadmill were recorded for the mice,
the number of shocks encountered was not a reliable measure of performance as
the shock panel became soiled at times resulting in inaccurate recording of the
number of shocks. Mice in the TGF-β1 injected group spent significantly less time
on the front half of the treadmill beginning at day 5 and progressively
deteriorating through day 13 as compared to those mice not treated with TGF-β1
(Figure 24).
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Figure 23: Histopathological evaluation of right knee medial compartments and
synovial lining for ADAMTS 5 KO mice following H/E staining. (A) 4x
magnification of saggital sections (medial compartment); (B) 20 x (left hand
panels) and 40x (right hand panels) of synovial lining. SF = synovial fluid;
(A)

(B)

Cage Controls

Cage + TGF-β1
Day 5
SF
SF
Hyperplasia

Mechanical Overuse +
TGF-β1 Day 18

Hyperplasia

SF

SF
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Hyperplasia

Figure 24: Percentage of time spent on front half of treadmill days 3 through 13
for mice in mechanical overuse and mechanical overuse + TGF-β1 groups
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Discussion and Conclusions
Recommendations from the Osteoarthritis Research Society for designing of
clinical trials to investigate disease-modifying activity state the primary outcome
should be a measure of joint structure or morphology—studies making use of
surrogate markers of cartilage destruction as an outcome are considered helpful,
but not sufficient alone (Altman et al., 1996).
The two intra-articular injections of TGF-β1 resulted in meniscal and
synovial hyperplasia and fibrotic changes on cartilage surfaces and joint capsule.
These alterations in tissue cellularity and structure persisted up to 14 days and
led to variable formation of chondro/osteophytes at the bone/cartilage margins,
and to extensive fibrotic remodeling of the synovial lining, the meniscal
attachment regions, and the cartilage surfaces (Figures 15 and 16). Most
notably, tissue remodeling in the vicinity of meniscal and cartilage fibrosis
resulted in the OA-like pathologies in the TGF-β1 treated joints. This is in keeping
with and extending the previously published data by others (Bakker et al., 2001;
Blaney Davidson et al., 2007; van Beuningen et al., 2000).
Additional exposure of TGF-β1 treated joints to controlled high intensity
treadmill running representing a biomechanical overuse resulted in more severe
cartilage pathology. Particularly, cartilage surfaces showed structural
irregularities that were more extensive and covered a greater percentage of the
surfaces (Figures 17-18). Individual lesions in certain regions, particularly the
medial tibial plateau were deeper and exposed subchondral bone. In addition,
the mechanical overuse induced damage to cartilages on the anterior surfaces of
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the TGF-β1 activated joint is consistent with the involvement of a biomechanical
factor in the development of the cartilage degeneration. Altogether, the
pathologies seen in this non-surgical model bear a closer resemblance to the
human disease pathogenesis and pathology than the surgically or chemically
induced mouse models of OA (Blom et al., 2004; Christ et al., 1988; Clements et
al., 2003; Guingamp et al., 1997; Janusz et al., 2001; Kamekura et al., 2005).
Interestingly, increased cartilage damage was also noted on the
cartilage surfaces of the contralateral knee in mice injected with TGF-β1 in both
cage and mechanical overuse groups. The degeneration was less severe than
in the injected joint, as assessed by India ink, but may point to involvement of
systemic factors in the initiation and progression of the joint tissue degeneration.
Indeed, involvement of contralateral and/or other joints has been frequently
reported in the human disease as well (Mazzuca et al., 2003; Spector et al.,
1994). In keeping with the notion that exercise alone does not play a part in the
pathogenesis of OA (Ettinger et al., 1997; Hootman et al., 2004; Roos et al.,
2005; Slemenda et al., 1998), mechanical overuse alone in the absence of TGFβ1 activated joint tissue remodeling did not result in detectable cartilage damage
In the context of joint tissue homeostasis, TGF-β1 has been proposed to
act through its anabolic effects on matrix. In vitro it is reported to stimulate
chondrocytes to increase production of proteoglycans and type II collagen
(Darling and Athanasiou, 2005; Pujol et al., 1991). In vivo stimulation of
proteoglycan synthesis has also been reported (van Beuningen et al., 1994). In
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addition TGF-β1 counteracts IL-1 up regulation of MMP-13 and MMP-14, which
are important in cartilage degradation (Blaney Davidson et al., 2007a).
TGF-β1 also plays an important role in wound healing, angiogenesis,
immunofunction, and cancers (Deed et al., 1997; Ellis and Schor, 1996;
Kobayashi and Terao, 1997; Wisniewski et al., 1996). Its overproduction leads
to many pathological conditions which include a range of fibrotic diseases such
as pulmonary fibrosis (Koli et al., 2008), glomerulosclerosis (Wang et al., 2007),
renal interstitial fibrosis (Ravinal et al., 2005), cirrhosis (Seki et al., 2007),
Crohn’s disease (Burke et al., 2007), cardiomyopathy (Khan and Sheppard,
2006), scleroderma (Pannu et al., 2006), and chronic graft-vs-host disease
(Lunn et al., 2005). Moreover, its involvement in the formation and progression
of cancers is twofold. Firstly, it suppresses the progression of early
transformations and tumorogenesis, but subsequent production of the factor by
cancer cells themselves promotes inflammatory matrix remodeling, cell
migration, and metastasis (Buijs et al., 2007).
Similarly, the role of TGF-β1 in our model of OA might be similar to such
dual actions on tissue remodeling. Firstly, high concentrations of TGF-β1 in the
joint clearly resulted in cell proliferation, migration, matrix production, and
remodeling converging in a more generalized fibrotic response. This in turn
permits the generation, activation, and survival of an altered cell type, such as a
myofibroblast, which in turn perpetuates a pro-inflammatory environment in the
joint (Bauer et al., 2006).
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Mechanical overuse is likely to produce mild injuries (or micro-trauma) to
cartilage surfaces. Whereas these superficial damages can be rapidly restored
in a healthy joint, the pro-inflammatory environment in a TGF-β1 activated joint
will perpetuate and progress into more advanced lesions. In addition to cellmediated perpetuation of damage in such joints, osteophyte development was
noted both on histology and radiography and these structures are well known to
impair normal joint mechanics (Felson et al., 2005).
In some surgically induced animal models, histopathology showed
increased cellularity and swelling of the collagen fibrillar structures of the
collateral, cruciate, and patellar ligaments. However these histologies were not
verified by quantitative parameters and therefore confirmative data to implicate
the involvement of ligament and tendon remodeling in the pathogenesis of this
model need to be confirmed biomechanically (Wang and Flatow, 2005).
The cartilage damage seen by India ink scoring was also confirmed
by FACE analysis. Mice receiving TGF-β1 injections had decreased total
chondroitin sulfate content in the knee joints compared to the controls
indicating changes in the cartilage structure. It appears that increased activity
in the absence of insult may actually be beneficial to cartilage health as the
chondroitin sulfate content of joints of mice who were subjected to high
intensity treadmill running without prior TGF-β1 injection was actually higher
than that of the control group.
ADAMTS-5 also plays a role in the development of OA in this model.
When subjected to the model, mice lacking the active form of this protease did
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not develop significant cartilage damage on India ink staining and histology.
Synovial hyperplasia was present at day 5 as was seen with the wild type
C57Bl/10 mice. However, at day 18 the cartilage surface integrity remained
intact. Determination of the mode of action of this enzyme during the TGF-β1
induced changes, such as synovial hyperplasia, will be important to further the
understanding of possible mechanisms of joint protection against OA in this
model.
Mice in the TGF-β1 injected group spent significantly less time on the front
half of the treadmill beginning at day 5 and progressively deteriorating through
day 13. This may indicate that their ability or motivation to run was impaired,
since the likelihood of encountering the shock panel is reduced by running on the
front half of the treadmill. Mice in this group endured more frequent shocks rather
than increasing their running speed to avoid sliding onto the shock grid. In
comparison, mice subjected to high intensity treadmill running in the absence of
TGF-β1 injections spent greater than 90% of the time on the front half of the
treadmill.
Data from the development of this non-surgical OA model are in support of
synovitis and soft-tissue activation in pre-OA joints possibly preceding and/or
accelerating the process of cartilage degeneration characteristic of progressive
and late stage osteoarthritis. ADAMTS-5 appears to play some role in the
development of these cartilage changes, but its role is not well understood. The
rapidity (13 days) and reproducibility of this non-surgical model of murine OA,
together with the rapid assessment of monitoring cartilage damage reported
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here, provides a platform for further work in evaluating both oral and intraarticularly administered therapeutics to modify joint pathologies leading to
advanced stage OA. In addition, the model presents a novel way of evaluating
non-pharmacologic interventions while maintaining the integrity of the supporting
joint structures.
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Chapter Four
Intra-Articular HA Injection Intervention
Research Design (Figure 25)
C57Bl/10 male mice aged 12 weeks old (n=36) were divided into the
following groups:
1.2 Cage + TGF-β1 +HA Day 5 (n=12): TGF-β1 injections, HA injection,
cage activity, sacrificed day 5
2.2 Cage +TGF-β1+HA Day 18(n=12): TGF-β1 injections, HA injection,
cage activity, sacrificed day 18
3.2 Mechanical Overuse+ TGF-β1+HA (n=12): TGF-β1injections, HA
injection, mechanical overuse via high intensity treadmill running,
sacrificed day 18
Mice from the previous experiments on the induction of OA-like changes were
used as the controls.
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Figure 25: Research design for intra-articular HA injection intervention
Day 1
Day 3
TGF-β1 Injection Right Leg
(2x 48 h interval)

Day 4
HA Injection
Right Leg

Cage
Day 5

A

Day 18

Sacrifice

Day 1
Day 3
TGF-β1 Injection Right Leg
(2x 48 h interval)

Day 4
HA Injection
Right Leg

Sacrif ice

Mechanical Overuse
Day 5
Day 18

B

Overuse through high intensity treadmill running
• Speed = 32 cm/ sec
• Duration = 20 minutes
• Frequency = daily x 13 days

111

Sacrifice

Materials
The following materials were used in addition to those listed in Chapter 3:
microplate reader (Bio-Tek Instruments, Inc., Winooshi VT); Multichannel pipettedigital (ICN ImmunoBiologicals, Costa Mesa CA); Mini-Orbital microplate shaker
(Bellco biotechnology, Vineland NJ); BioTek Automated Microplate Washer
Model EL 403 (BioTek Instruments, Inc., Winooshi VT); Nunc-Immuno Plate I F
(VWR Scientific, Philadelphia PA); Microwell Plates (VWR Scientific, Philadelphia
PA); Microplate sealing tape VWR Scientific, Philadelphia PA); microplate plastic
lid (VWR Scientific, Philadelphia PA); reagent reservoir for multichannel pipette
(ICN ImmunoBiologicals, Costa Mesa CA); monoclonal anti-keratan sulfate
antibody 5D4 (ICN ImmunoBiologicals, Costa Mesa CA); horseradish
peroxidase-conjugated anti-mouse IgG (Pierce Chemical Company, Rockford IL);
chondroitin ABC Lyase (ICN ImmunoBiologicals, Costa Mesa CA); Tween 20
(Sigma Chemical Company, St. Louis MO); Bovine serum albumin (Sigma
Chemical Company, St. Louis MO); O-phenylenediamine (Sigma Chemical
Company, St. Louis MO); SupartzTM high molecular weight HA (Seikagaku, Inc.).

Methods
Animal Husbandry
In vivo experiments were conducted with C57Bl/10 male mice procured
from Jackson Laboratories at 7-11 weeks of age and housed at the Rush or the
University of South Florida animal facility until they were 12 weeks old. All
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procedures for mouse handling, intra-articular TGF-β1 injections and mechanical
overuse through high intensity treadmill running were as described in Chapter 3.

Intra-Articular HA Injections
To determine the effects of intra-articular injections of HA, mice received
two doses of HA (10 µl of 5mg/ml Supartz in 6 µl saline) into the intra-articular
space of the right knees on the same day with approximately 30 minutes
between injections. These were performed using a 28G x ½ inch needle on 0.5
ml syringe. Prior to HA injections, anesthesia was administered as described
previously.

Tissue Harvesting
Hind limbs were harvested from euthanatized animals for histopathological
evaluation via transection of the mid shaft of the femur as described in Chapter 3
and fixed for histology or stored at -20° C until evaluation with India ink.

Determination of Clearance Time of HA from the Knee Joint Space
Mice were injected with 6 µl (5mg/ml) fluorescein isothiocyanate (FITC)labeled Supartz (endotoxin free and sterile, provided by Seikagaku Corporation,
Tokyo, Japan) into the joint space of both knees in naïve (n = 5) and TGF-β1
treated C57Bl/10 mice (n = 5) . In addition a metabolically inactive (humanely
euthanatized via carbon dioxide) mouse was also included to determine the
requirement of live-tissue for HA clearance from the joint and the extent to which
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FITC fluorescent signal intensity was decreased by the repeated UV exposures
during multiple imaging time points. -injection. Whole body and knee joint
imaging was performed on the KODAK Molecular Image Station-In Vivo FX and
Kodak Molecular Imaging Software. Fluorescent images were obtained under UV
transillumination using a 465 nm excitation filter, a 535 nm emission filter, f-stop
(focal length divided by the diameter of the lens) at 5.8, and a field of view of 60
mm. Images were obtained at baseline (immediately following injection), and 45
minutes, 1 hour, 3 hours, 6 hours, 12 hours, and 22 hours post injection.
Radiographs were also taken at each imaging time point as described previously
and overlays with fluorescent images used to determine the spatial distribution of
fluorescence relative to the intra-articular space.
Quantification of the fluorescence was determined on overlaid images
within five mm diameter circular regions of interest (ROI) surrounding the intraarticular space (Figure 26). Using the Kodak Molecular Imaging Software, the net
intensities (pixels) of the ROIs were imported into an Excel spreadsheet.
Averages and standard deviations were calculated for each group at each time
point.
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Figure 26: Selection of regions of interest on fluorescent image corresponding to
radiographic images for determining net intensity of fluorescence within the knee
joint in FITC-labeled HA injected mice and overlay of radiograph and fluorescent
images
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Blood Collection and Plasma Preparation
Animals were anesthetized as described previously and blood (5-7 drops
for in vivo time points and terminal bleeds at time of sacrifice) was collected from
the submandibular vein after puncture with a sterile 18G needle. Collections were
done at baseline, two days after the first TGF-β1injection (day 3), two day after
the second TGF-β1injection (day 5), one week after the second TGF-β1injection
(day 12), and 14 days after the second TGF- β injection (day 18). Blood was
collected into sterile 500 µl eppendorf tubes containing 5 µl of heparin, cells were
removed by centrifugation at 13,000 rpm for ten minutes at room temperature,
plasma supernatants removed, and stored at -80º C until further analyses.
In addition, blood was collected as described above at the time of sacrifice
from 56 male C57Bl/10 naïve and TGF-β1 injected mice to determine HA
concentration in the plasma at the following time points (n=4): baseline (prior to
HA injection), 1 hour, 3 hours, 6 hours, 24 hours, 7 days, and 14 days after
injection of HA.

Determination of Plasma HA Concentration by HA ELISA
Plasma samples were analyzed for HA content using ELISA, essentially
as described (Li et al., 1989; Rayan et al., 1998; Thonar et al., 1992) Briefly,
keratan sulfate-free aggrecan from rat chondrosarcoma (RCS D1) was digested
with chondroitinase ABC, then coated onto immunoplates in a sodium
carbonate/sodium bicarbonate/sodium azide buffer at a concentration of 6 µg/ml.
HA (present in the standard and the samples) will bind specifically to the
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immobilized RCS-D1 G1 domain. A second aggrecan preparation from bovine
articular cartilage D1 (BAC D1), which contains keratin sulfate is then introduced
into the reaction mixture to bind to the immobilized HA. Finally, the bound keratin
sulfate containing aggrecan is quantitated using an anti-keratin sulfate antibody
(5-D-4) and horseradish peroxidase labeled anti-mouse IgG (an enzyme-linked
secondary antibody). After adding O-phenylenediamine substrate, a color
reaction occurred turning the samples orange (Figure 27). The intensity of the
color reaction was proportional to the amount of HA antigen present in the
sample. The concentration of HA present in each sample was then calculated by
comparison of the absorbance values in each case to a standard curve
generated from a known concentration of HA treated in the same way and
incorporated in the same plate. Data from the ELISA was used for comparisons
of change over time within and between groups.
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Figure 27: Schematic representation of HA ELISA. (1) RCS-D1 is immobilized
on immunoplate; (2) HA from standard and samples binds specifically to the
RDS-D1 coated plate; (3) BAC D1 detects HA; (4) anti-keratin sulfate antibody
(5-D-4) binds to BAC D1; horseradish peroxidase labeled anti-mouse IgG binds
to 5-D4; (5) o-phenylenediamine substrate is added and substrate-enzyme color
development occurs

OPD Substrate
Product “Orange”
HRP
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BACD1-KS
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Data Evaluation: Statistical Parameters
Statistical analyses were performed using Statistical Package for Social
Sciences (SPSS) version 15.0 for Windows as described in Chapter 3.

Results and Analyses
Clearance Time of HA from the Knee Joint Space
In situ whole body imaging of mice that received injections of FITC-labeled
HA was firstly used to determine the accuracy and quantitative delivery of HA
into the joint space (Figure 28). The total amount of fluorescence detected
immediately after injection into naïve joints was 19,000,000 + 4,000,000 pixel
density units compared with 7,500,000 + 1,250,000 pixel density units for TGFβ1 injected joints and the proportional difference remained essentially constant
over the entire range of image points. The lower intensity of fluorescence
obtained with TGF-β1 treated knees using the same amount of starting material
injected might have resulted from enhanced quenching of fluorescence bound up
by de novo accumulated tissues and matrix after TGF-β1 injection, such as
hyperplastic patellar fat pad (see Figure 16). An altered partitioning of
macromolecules injected into TGF-β1 treated joints was confirmed by injecting
Alexa 680 labeled hyaluronan binding protein (HABP) into naive and treated
joints, which showed a concentration of fluorescence in region of the infrapatellar
fat pad of mice injected with TGF-β1 (Figure 28).
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Figure 28: Fluorescent imaging with FITC labeled HA and Alexa 580 HABP
shows concentration of fluorescence in region of the infrapatellar fat pad of mice
injected with TGF-β1 and more diffuse fluorescence throughout the knees of
mice not injected with TGF-β1
naive

TGF-β1-treated

FITCHA

Alexa 580
HABP

120

Using the in vivo imaging technique, it was determined that the half life (t1/2) of
the injected FITC-HA is approximately 6 hours in naïve joints and is increased to
12 hours in the TGF-β1 injected joint (Figure 29). Furthermore, the clearance
kinetics displayed a fast phase (0-6 hours) followed by a slower phase (6-22
hours; Figure 30). The fast turnover pool might represent lymphatic clearance of
a freely diffusible pool of injected HA (Sabaratnam et al., 2003). The second,
slower turnover pool is most likely HA molecules that have become incorporated
into the ECM, remain bound to HA-specific receptors on the cell surface, or
accumulate intracellularly in endocytotic vesicles (Tammi et al., 2001).
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Figure 29: HA fluorescence in knee joints of mice injected with TGF-β1, mice not

Fluorescence Unit (Pixels per ROI)

injected with TGF-β1, and mice that are metabolically inactive (MI)
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Figure 30: HA clearance from knee joints of mice injected with TGF-β1 and mice
not injected with TGF-β1. Half life indicated as t1/2

t1/2 ~ 12 hours
t1/2 ~ 6 hours
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HA Concentration in Plasma Following Intra-Articular Injections of HA
ELISA is a widely used, sensitive and highly specific biochemical
technique for the detection of macromolecules (proteins, polysaccharides) in a
given sample. The particular ELISA method used here was developed for the
detection of polymeric HA in biological fluids and tissue digests (Li et al., 1989;
Rayan et al., 1998; Thonar et al., 1992). The range of detection of this assay is
between 10 and 1000 ng of polymeric HA per ml of sample. A recent study
employing this method to determine HA levels in serum of healthy individuals and
persons diagnosed with OA revealed an increase of serum HA in persons with
OA. Moreover, significant correlations existed between elevated HA levels and
disease duration, citing it as a possible biomarker of disease activity (Turan et al.,
2007).
Baseline (pre-HA injection) concentrations of HA showed a variation
between the two groups of mice used. The TGF-β1 injected mice had lower preHA injection (baseline) plasma concentrations of HA than non-TGF-β1 injected
mice (Figure 31). All animals were maintained at the same activity level and bled
at the same time of day after receiving the same amount of anesthesia. The only
difference between these mice at baseline (before HA injection) was previous
activation of the joints TGF-β1 injection in one group.
Both groups demonstrated low levels of plasma HA between three and
twelve hours after HA injection. These time points correspond to the times
during which maximal rate of clearance of HA from the joint occurs (see Figure
30). This might indicate diurnal variations or activation of hepatic mechanisms by
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the HA cleared from the plasma (Laurent et al., 1996). These interesting
fluctuations in plasma HA warrant further examination to determine the
underlying biochemical mechanisms. However, such experiments are outside the
scope of this project due to the number of animals required for such studies.
Moreover, the objective of this experiment in the context of this thesis has been
addressed, which was to determine if intra-articularly injected HA is cleared via a
systemic route.

125

Figure 31: Plasma HA concentrations for TGF-β1 injected and non-TGF-β1
injected mice from pre-injection (baseline) to 14 days after HA injection as

Concentration (ng/ml)

measured by HA ELISA
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Effect of Intra-Articular HA on Joint Pathology
India ink staining of both the right femoral and tibial cartilage surfaces
revealed that intra-articular injections of HA resulted in less cartilage damage
(lesions and fibrillation/fibrotic changes) after both cage activity and mechanical
overuse via high intensity treadmill running (Figures 32-33). Groups treated with
HA had significantly less cartilage damage (<1.33 on femoral surfaces and <
0.67 on tibial surfaces) than those not treated with HA. Scores were virtually
identical to those obtained for naïve animals (Figures 17-18).
To examine whether the protective effects of HA were due to systemic
changes, in another group of mice HA was injected into the contra lateral joint.
However, administration of HA via this route did not show any effect on
prevention of cartilage lesions, cell proliferation in the synovial tissues, or
osteophyte formation in the TGF-β1 injected knee. Moreover, doubling the
dosage of HA from 10 µl to 20 µl into the affected knee did not reveal any
additional joint protective effects when compared to the single dose.
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Figure 32: Mean cartilage scores for right femurs by quadrant after HA
intervention. 1= TGF-β1 + HA; 2 = TGF-β1 with no HA; 0 depicts no cartilage
damage
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* denotes statistically significant difference from controls and non-HA injected groups at
p<0.05;
** denotes statistically significant difference from controls and non-HA injected
groups at p<0.005
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Figure 33: Mean cartilage scores for right tibias by quadrant after HA
intervention. 1= Cage + TGF-β1 + HA; 2 = Cage + TGF-β1
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p<0.01;
*** denotes statistically significant difference from controls and non-HA injected
groups at p<0.005
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Figure 34: Percentage of time spent on front half of treadmill days 3 through 13
for mice in the mechanical overuse, mechanical overuse + TGF-β1, and
mechanical overuse + TGF-β1 + HA groups
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Discussion and Conclusions
Intra-articular injection of HA at a single, early time point in this OA model
reduced the formation of cartilage lesions induced by TGF-β1 alone or in
combination with mechanical overuse (Figures 32-33). The mean cartilage
scores in treated animals were decreased from approximately 2.4 to 0.6 in each
quadrant. This supports similar findings in studies done on surgical models of OA
in rabbits (Amiel et al., 2003; Takahashi et al., 1999).
Histological examination of the mouse joints (data not shown) revealed
that a significant effect of the chondroprotection in this model might be the result
of inhibition of fibrotic tissue formation within the synovium and at the articular
cartilage surface, as well as reduced osteophyte development. In support of the
conclusion that the injected HA had a direct effect on the pathological cell
proliferation and tissue remodeling induced by TGF-β1 was the finding that HA
injected into the contra lateral control joint had no effect on the development of
fibrosis and cartilage lesions in the affected joint. Moreover, injection of saline
alone into either the diseased or contra lateral control knee also provided no
therapeutic effect. Further work is needed to identify the cell types and their
receptors that mediate the joint protection in this model.
The inhibition of fibrosis seen here is consistent with anti-adhesion
properties of HA reported in abdominal and ophthalmic surgeries. In addition, HA
is reported to enhance angiogenesis and cell migration, thereby augmenting the
granulation phase of wound healing. Similar mechanisms may come into play in
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the chondroprotective role of HA observed here.
A largely direct therapeutic efficacy of HA on the tissues within the joint, as
opposed to an indirect systemically mediated effect, was supported by the data
that rapid clearance of HA from the joint within 24 hours (Figure 30) was not
accompanied by concurrent increase in the levels of circulating HA (Figure 31).
This would be keeping with clearance pathways involving the lymphatic route to
the liver (Johnson et al., 2007). Interestingly, serum levels of HA were decreased
during the maximal clearance activity from the joint which happened in the first
six hours post injection (Figure 29). As systemic HA is also removed by the liver
(Fraser and Gibson, 2005), this finding might indicate a direct coupling of
lymphatic and systemic HA clearance pathways by the liver.
Mice that had been injected with TGF-β1 spent significantly less time on
the front half of the treadmill beginning at day 5 (<90%) and progressively
deteriorating through day 13 (<75%). This would seem to indicate that their ability
or desire to run was affected since the likelihood of encountering the shock panel
is reduced by running on the front half of the treadmill. The mice in this group
endured more frequent shocks rather than increasing their running speed to
avoid the noxious stimuli. The HA intervention mitigated this functional
consequence as HA treated mice spent greater than 95% of the time on the front
half of the treadmill (Figure 34) and suggests an analgesic effect of HA in this
model. .
Clearly, intra-articular injections of HA may not function solely to restore
viscoelastic and protective functions of HA in the joint as previously thought
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(Balazs and Denlinger, 1993). The beneficial effects seen here last longer than
the half life of the injected HA, which is 18-24 hours (Kotz and Kolarz, 1999), and
support findings in human studies that pain relief from intra-articular injections of
HA occurs, and lasts 26-52 weeks (Altman and Moskowitz, 1998; Huskisson and
Donnelly, 1999; Kotz and Kolarz, 1999; Leardini, et al., 1987; Puhl et al., 1993;
Wobig et al., 1998).
Thus, in addition to the application of the mouse model for studying the
mechanistic effects of intra-articular HA therapy, it will be useful for pre-clinical
testing of existing and new formulations of HA preparations for their efficacy as
well as disease modifying products during the progression of tissue destruction.
The potential benefits of combination of such injections with physical therapy can
also be investigated.
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Chapter Five
Aerobic Exercise Intervention
Research Design (Figure 35)
C57Bl/10 male mice aged 12 weeks old (n=54) were divided into the
following groups:
1.3 Cage +TGF-β1+ exercise Day 5 (n=12): 4 weeks aerobic exercise,
TGF-β1 injections, cage activity, sacrificed day 5
2.3 Cage + exercise Day 5 (n=6): 4 weeks aerobic exercise, cage
activity, sacrificed day 5
3.3 Cage +TGF-β1 + exercise Day 18 (n=12): 4 weeks aerobic exercise,
TGF-β1 injections, cage activity, sacrificed day 18
4.3 Cage + exercise Day 18 (n=6): 4 weeks aerobic exercise, cage
activity, sacrificed day 18
5.3 Mechanical Overuse + TGF-β1 +exercise Day 18 (n=12): 4 weeks
aerobic exercise, TGF-β1 injections, mechanical overuse via high
intensity treadmill running, sacrificed day 18
6.3 Mechanical Overuse + exercise Day 18(n=6): 4 weeks aerobic
exercise, overuse via high intensity treadmill running, sacrificed day
18
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Figure 35: Research design for aerobic exercise intervention
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Methods
Details are described in Chapters 3 and 4. C57Bl/10 male mice procured
from Jackson Laboratories at 7-11 weeks of age were housed at the Rush animal
facility until they were 12 weeks old. All mouse husbandry and handling
experimentations were carried out as described..

Aerobic Exercise via Alternate Day, Low Intensity Treadmill Running
The experimental group of mice underwent treadmill running at a speed of
14 cm/second for 20 minutes on alternate days for a period of four weeks. This
was determined with the same formula as for high intensity treadmill running.
Thus, low intensity aerobic exercise for the mouse at 50% vO2 is achieved at 14
cm/sec (Baker and Gleeson, 1999). Treadmill exercising was performed at the
same time each day for all groups. It represented a significant increase in
physical activity for each animal because it was performed during the day when
mice are usually sleeping, resting, or showing minimal physical activity.
Following the four week exercise period, the mice were injected with TGFβ1 as described previously and then underwent 13 days of either cage activity or
high intensity treadmill running as described previously. Controls for these
groups were taken through the same exercise intervention then maintained with
cage activity or high intensity running, but did not receive TGF-β1 injections.
A daily record was kept for each animal. It included: duration of the run
(minutes), distance run (calculated from the run time and speed of the treadmill),
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and number and time of interactions with the shock grid. In addition, treadmill
performance was measured by the amount of time each mouse stayed on the
front half of the running treadmill.
In addition, to ensure that the effects of inducing this model were the same
for 16 week old mice as they were for 12 week old mice, 16 week old male mice
were divided into 3 groups: Cage + TGF-β1 Day 5, Cage + TGF-β1 Day 18, and
Mechanical Overuse + TGF-β1 Day 5. These mice received TGF-β1 injections as
described previously followed by either cage activity or mechanical overuse via
high intensity treadmill running.

Data Evaluation: Statistical Parameters
Statistical analyses were performed using Statistical Package for Social
Sciences (SPSS) version 15.0 for Windows. Cartilage scores for all four
quadrants were analyzed individually then summed to obtain the overall cartilage
score for each cartilage surface (right femur, left femur, right tibia, and left tibia).
In addition, quadrants 1 and 2 were summed for the anterior surface score,
quadrants 3 and 4 for the posterior score. Finally quadrants 1 and 3 were
summed for the lateral cartilage score and quadrants 2 and 4 for the medial
cartilage score.
Data was analyzed for descriptive statistics (means, medians, standard
deviations) and fixed effect one way analysis of variance (ANOVA) with Tukey
post hoc testing and level of significance at p value less than 0.05. Group
comparisons were made for overall cartilage scores, total scores for each
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cartilage surface (right femur, left femur, right tibia, and left tibia), anterior,
posterior, medial and lateral areas of each cartilage surface, and each quadrant
(anteromedial, anterolateral, posteromedial, and posterolateral) on each cartilage
surface. Power analysis based on the 4 point grading system and with the
assumption based on preliminary studies of a between group mean difference of
at least one point revealed a sample size of 3 in control groups and 6 in
treatment groups per time point sufficient for power >80%.
In addition Repeated Measures ANOVA with Tukey post hoc testing and
level of significance at p value less than 0.05 was used to analyze data on
treadmill performance data. The time each mouse spent on the front half of the
treadmill each day was expressed as a percentage of the total time and data
were analyzed for descriptive statistics and differences within and between
groups and within and between days.
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Results and Analysis
Effect of Exercise Intervention on Joint Pathology
There was a statistically significant difference between cartilage scores for
the groups receiving exercise as an intervention prior to inducing OA-like
changes through TGF-ß1 and mechanical overuse and those that did not with the
exercised mice having lower scores. This difference was apparent on both the
femur (Figure 36) and tibia (Figure 37) cartilage surfaces at day 18. Cartilage
scores for the femoral condyle cartilage surfaces were higher than those for the
tibial plateau cartilage surfaces indicating the involvement of a prominent
biomechanical component in the pathway leading to cartilage damage. No
statistically significant difference existed between exercise groups and controls.
However, scores trended slightly higher in the exercise groups than in the
controls.
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Figure 36: Mean cartilage scores for right femurs by quadrant after exercise
intervention (1 = exercise; 2 = TGF-β1; 3 = exercise + TGF-β1)
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Figure 37: Mean cartilage scores for right tibias by quadrant after exercise
intervention (1 = exercise; 2 = TGF-β1; 3 = exercise + TGF-β1)
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Treadmill Performance
There was a statistically significant difference between groups in treadmill
performance (p<0.05) with the exercised mice spending more time on the front
half of the treadmill compared to the non-exercised, TGF-β1 injected mice. This
difference was apparent in overall average daily times as well as daily times on
days 8 through 13 (Figure 38). Mice in the exercise intervention groups averaged
above 90% on a daily basis as did the mice undergoing mechanical use only in
the absence of TGF-β1 injection. However, mice in the mechanical overuse +
TGF-β1 group showed a steady decline in treadmill performance beginning day 5
and progressively worsening through day 13 when they spent less than 75% of
the time on the front half of the treadmill.
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Figure 38: Percentage of time spent on front half of treadmill days 3 through 13
by group for mice in the mechanical overuse, mechanical overuse + TGF-β1,
and mechanical overuse + TGF-β1 + exercise groups
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Discussion and Conclusions
A four week period of alternate day, low intensity treadmill running
minimized cartilage damage from TGF-β1 injections and overuse in our mouse
model of OA. While cartilage damage was not entirely eliminated, the mice that
exercised via low intensity treadmill running showed significantly less cartilage
damage than those mice who did not exercise. Mice in exercise groups scored
minimal cartilage fibrillation or less on femurs and tibias at day 18 of both cage
activity and overuse compared to mice in non-exercise groups that scored overt
cartilage erosion to ulceration (Grades 1 and 3, respectively; See Figure.12).
The effect of treadmill exercise on OA pathogenesis in mice has not been
studied. The findings reported here, that pathological effects of joint inflammation
(synovitis, capsular fibrosis) did not proceed to induction of cartilage lesions in
exercised mice, are also supported by another study showing that voluntary
wheel running slowed the progression of spontaneous OA in mice expressing a
col IIa mutation (Lapvetalainen et al., 2002).
Possible mechanisms for this protective effect warrant further
investigation, but may include biochemical and/or biomechanical pathways.
Although strengthening is not a primary outcome of aerobic exercise, it is
possible that the four week exercise program resulted in increased hind limb
muscle strength. Studies in humans have found that increased quadriceps
strength (in the presence of normal joint biomechanics) results in a decreased
risk of OA (Hootman et al., 2004; Slemenda et al., 1998). By improving muscle
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balance and strength, stress and structural trauma to the cartilage may be
reduced.
Another possible mechanism may be related to the increased production
and deposition of aggrecan in the cartilage itself. In a study of exercise in
humans, Roos et al. found aerobic exercise improved cartilage quality as
evidenced by increased GAG content measured by dGEMRIC (Roos et al.,
2005). While total proteoglycan contents (as chondroitin sulfate by FACE, see
Chapter 3) was not analyzed for the mice in the exercise intervention, FACE
analysis on the mice undergoing high intensity aerobic exercise in the absence of
TGF-β1 injections showed increased chondroitin sulfate content of the cartilage.
It is reasonable to hypothesize the mice in the exercise intervention groups may
also have increased chondroitin sulfate content.
Mice undergoing exercise without TGF-β1injections scored slightly (but
not significantly; p > 0.70) higher than controls for cartilage damage as graded by
India ink stain. This may be in part a result of the age of mice in the exercise
group being four weeks older than the model controls. C57Bl mice spontaneously
develop OA with increasing incidence and severity with age. At eight weeks, 20%
have some evidence of OA on histology. This increases to 80% at 64 weeks
(Yamamoto et al., 2005). It is possible the additional four weeks resulting in some
increased cartilage fibrillation. However, no difference was noted in cartilage
grading when comparing 16 and 12 week old mice. In addition to structural
changes noted with inducement of this OA model and remediated with
interventions of HA injections and exercise, there appeared to be functional
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consequences as well in the form of altered treadmill performance. Mice in the
exercise intervention group spent greater than 90% of the time on the front half of
the treadmill as compared to mice in the non-exercise group which spent < 90%
of the time on the front half of the treadmill beginning at day 8 and worsened to
<75% by day 13 of the mechanical overuse protocol. This would seem to indicate
the exercised mice had a better ability or desire to run.
Studies on the effects of mechanical perturbation on degenerative and
reparative actions of chondrocytes have been performed ex vivo (Fitzgerald et
al.; 2006, Lee et al, 2005; Sah et al., 1989). In addition, low magnitude
mechanical strain on cartilage has been shown to suppress IL-1 and TNF-α (proinflammatory cytokines) and up regulate proteoglycan and collagen synthesis
while high magnitude mechanical strain was detrimental in vitro (Deschner et al.,
2003). This model may provide a means of examining cellular and biochemical
events involved in the complex function of joint movement and determining doseresponse relationships of mechanical forces and cartilage health as well as
responses to different types of force (shear, compression, friction, combination).
The data reported represents the first time report of aerobic treadmill
exercise in mice as a possible intervention for minimizing the development of OA
in the knee joint. The non-surgical mouse model developed here will allow further
mechanistic studies of aerobic exercise as well as other types of exercise, such
as resistance exercise. In addition it will be useful for determining dose-response
relationships of exercise and the effects of timing of exercise on OA development
and progression.
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Chapter 6
Summary and Conclusions
Significance and Implications
Comprehensive OA-like changes in mouse knee joints can be induced by
anabolic stimulation of joint tissues through intra-articular injections of TGF-β1
followed by mechanical overuse of the activated joint. Specific changes noted
initially following TGF-β1 injection include synovial hyperplasia, cellular
infiltration, and granulation tissue formation. Within two weeks these changes
progressed to soft tissue fibrosis, chondrophyte/ osteophyte development, and
degeneration of the articular cartilage and menisci. This pathology was enhanced
after mechanical overuse through daily high intensity treadmill running.
Functional consequences of the pathology in this model also occurred, and was
detected by poorer treadmill performance of the mice injected with TGF-β1
compared to untreated mice..
Development of this non-surgical mouse model of OA provides a tool for
studying the development and progression of OA as the knee is not destabilized
by surgical procedures or the introduction of noxious substances in the joint
space. While in the past spontaneous age-related or genetic mouse models were
used, they require housing for an extended period of time significantly to the cost
of research. Genetic manipulation models are often not amenable to
interventions as a result of the genetic alteration (Bendele, 2002). The rapidity of
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the mouse model of OA presented in this research makes it an option for
studying OA development. Further, the presence of pathological joint changes in
an otherwise intact knee joint makes it amenable for pharmacological and nonsurgical intervention studies.
Utilization of this model has shown that intra-articular injections of HA may
have a disease-modifying effect on the development of OA. Mice injected with
HA immediately following anabolic stimulation of the joint with TGF-β1 still
exhibited the initial synovial hyperplasia but did not continue to develop fibrosis,
chondrophyte/osteophyte formation, or cartilage and meniscal degeneration even
after mechanical overuse of the activated joint. Further, treadmill performance of
mice injected with HA remained the same as that displayed by normal mice. HA
injections are used in humans to treat the symptoms of OA, primarily pain.
However, data obtained in this study indicate HA injections may be able to
actually alter the disease process and impact the functional consequences of
OA.
The model developed here was also used to demonstrate a preventative
effect of aerobic exercise on disease development in OA in mice. The mice that
were subjected to four weeks of alternate day, low intensity treadmill running
prior to the inducement of OA developed less cartilage damage than nonexercised mice. In addition, this intervention also appears to have positively
impacted function as treadmill performance in OA induced exercised mice did not
show the progressive decline seen in OA induced, non-exercised mice. This is
the first study investigating the effects on OA in mice of aerobic exercise through
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low intensity treadmill running, and findings support those of Lapvetalainen et al.,
in a study of lifelong voluntary wheel running in mice (Lapvetalainen et al., 2002).
Further, this research indicates aerobic exercise may have a disease-modifying
effect and warrants more investigation.
In addition it was shown that 13 days of mechanical overuse alone was
not sufficient to cause significant cartilage degeneration and other joint changes.
This supports findings of studies in human OA that repetitive, high intensity
exercise in the absence of altered joint biomechanics does not result in increased
OA development (Bennell and Hinman, 2005; Cymet, 2006).

Limitations
While the data presented here suggest OA-like changes can be induced in
mouse knees through TGF-β1 injections followed by mechanical overuse, and
both HA injections and aerobic exercise intervention decrease OA development,
limitations do exist. Translation of these results into treatment of human disease
needs to be further investigated. Mouse models are commonly utilized to test an
intervention effect and to determine disease and intervention mechanisms.
However, studies of this kind need to be repeated in larger animals before
introduction to human patients.
A large variability was noted in baseline concentrations of serum HA
during the HA ELISA. This large variability requires a much larger sample size
than that used here in order to draw more definite conclusions. A small sample
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size was also used for the serum TGF-β1 ELISA. Therefore, the data reported for
both the HA and TGF-β1 ELISAs should be treated as preliminary data.
The data suggests that mechanical overuse in the absence of TGF-β1
activation does not result in OA development. However, it must be pointed out
that the mechanical overuse was only for 13 days. While this represents
approximately 2% of a mouse’s life (or approximately 1 ½ years for humans),
whether a more extended period of mechanical overuse would still result in little
or no joint disease remains to be seen.
The duration of the chondroprotective effects of the HA intervention and
the aerobic exercise intervention is uncertain. The results reported here show
effects at 14 days post TGF-β1 injection. However, whether the inhibition of
cartilage degeneration persists beyond two weeks is not known.

Future Directions
While the specific aims for this dissertation were addressed, many
questions remain unanswered and provide opportunity for further research. The
mechanism of OA development in this non-surgical model is not completely
understood. It is evident that the synovial hyperplasia and cellular infiltration
occurs, but it is less clear what cells are present and from where they originate.
Immunohistochemistry and other biochemical techniques may assist in
determining this.
Histological assessment of TGF-β1 injected knees indicates there may be
disruption of the menisci and ligaments that stabilize the knee joint. If so, faulty
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joint biomechanics may be partially responsible for the joint damage reported
here. Ligamentous integrity should be investigated to determine what role, if any,
the ligaments play in the development and progression of OA in this model.
ADAMTS 5 appears to be involved, at least in part, in this non-surgical
mouse model of OA. Further studies with ADAMTS 5 knockout mice are
warranted to investigate the extent of involvement and specific role of ADAMTS
5. In addition, other knockout strains should be utilized to investigate the role of
other proteases.
The duration of chondroprotection seen with intra-articular HA injections
warrants more investigation, as does the actual onset of this inhibition of cartilage
damage. It is clear that synovial hyperplasia still occurs at day 5 even in the
presence of HA. However, it is not know if the same cell types are present.
Protection of the cartilage surfaces is evident at day 18, but what occurs between
day 5 and day 18 of this model remains to be studied. Further, the importance of
the timing of HA injection and the effect of multiple injections at various time
points should be investigated. This research shows injection of HA one day after
inducing OA minimizes OA development, but it is not known if HA injected later in
the disease process continues to offer protection and/or has a reparative role.
The disease-modifying effects of exercise on OA have not been well
studied. The data reported here show a preventative bout of aerobic exercise
prior to the inducement of OA provides chondroprotection. The mechanism(s) of
this chondroprotection warrant further investigation via histological, biochemical,
and biomechanical assessment. Future exercise studies should be undertaken
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with this model to determine what type (aerobic, resistance, water-based), dose
(intensity, frequency, duration), and timing (preventative, early disease, mid
disease, late disease) of exercise provides optimal joint benefits.
The mouse model developed as part of this dissertation provides a means
to answer these and other questions. Further, the development of procedures for
intra-articular HA injections, treadmill exercise, and rapid data analysis methods
facilitate investigation of the development and progression of OA and the effects
of other pharmacological and non-pharmacological interventions.
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Appendices
Appendix 1: Abbreviations used
ACL
ACR
ADAMTS
AGS
AIMS
ANOVA
BAC
BMI
BMP
BSA
C
CES-D Scale
CILP
CRP
CT
Da
dGEMRIC
DI
DJD
ECM
EDTA
ELISA
ETOH
EULAR
FACE
FITC
FRZB
g
G
GAG
H/E
HA
hr
IGF-1
IL
iNOS
kg
km
KO

anterior cruciate ligament
American College of Rheumatology
a disintegrin and metalloproteinase with thrombospondin
motifs
American Geriatric Society
Arthritis Impact Measurement Scale
Analysis of variance
bovine articular cartilage
body mass index
bone morphogenetic protein
bovine serum albumin
Celcius
Center for Epidemiological Studies—Depression Scale
Cartilage Intermediate Layer Protein
C-reactive protein
computed tomography
dalton
delayed gadolinium-enhanced magnetic resonance imaging
De-ionized
degenerative joint disease
extracellular matrix
Ethylenediaminetetraacetic acid
enzyme linked immunoassay
ethyl alcohol
European League Against Rheumatism
Fluorophore-assisted Carbohydrate Electrophoresis
fluorescein isothiocyanate
frizzled related protein
gram
gauge
glycosaminoglycan
hematoxylin/eosin
hyaluronan
hour
insulin-like growth factor 1
interleukin
Inductible nitric oxide synthetase
kilogram
kilometer
Knock out
191

Appendix 2 (continued): Abbreviations
KOOS
LCL
LYVE-1
m
M
mA
MCL
mg
ml
MMP
MOVE
MRI
mRNA
NFR
ng
nm
NSAID
OA
OARSI
OASI
PCL
PDGF
PG
RPE
rpm
sec
SF-36
SPP
SPSS
sR
TEFR
TGF-β1
TNFAIP
TNF-α
US
V
VO2 max
WOMAC
µl

Knee Osteoarthritis Outcomes Survey
lateral collateral ligament
lymphatic vessel endothelial HA receptor
meter
molar
milli amperage
medial collateral ligament
milligram
milliliter
matrix metalloproteinase
magnetic resonance imaging
messenger ribonucleic acid
nociceptive flexion reflex
nanogram
nanometer
non-steroidal anti-inflammatory
osteoarthritis
Osteoarthritis Research Society International
Osteoarthritis Severity Index
posterior cruciate ligament
platelet derived growth factor
proteoglycan
rating of perceived exertion
revolutions per minute
second
Short Form Health Survey General Questionnaire
suprapatella pouch
Statistical Package for Social Sciences
soluble receptor
Therapeutic Education and Functional Readaptation
transforming growth factor-beta 1
tumor necrosis factor-alpha induced protein
tumor necrosis factor-alpha
ultrasonography
volt
maximal voluntary oxygen uptake
Western Ontario and MacMaster’s University Osteoarthritis
Index
microliter
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Appendix 2: Reported outcomes of exercise in persons with OA
Study

Sample
Size
Mangione n=39
et al.
(1999)

Type of
Exercise
Aerobic

Outcomes

Kovar et
al.
(19992)

n=102

Aerobic

Minor et
al. (1989)

n=120

Aerobic

Minor et
al. (1989)

n=120

Waterbased

Ettinger
et al.
(1997)
Penninx
et al.
(2002)
Rejeski
et al.
(1998)
Schilke
et al.
(1996)

n=439

Aerobic

n=439

Aerobic

Improved timed chair rise
Improved six minute walk test
Improved walking speed
Decreased overall pain
Improved aerobic capacity
Decreased pain
Less medication use
Increased walking distance
Increased function (AIMS)
Improved aerobic capacity
Improved 50 feet walking time
Decreased depression
Decreased anxiety
Improved physical activity
Improved aerobic capacity
Improved 50 feet walking time
Decreased depression
Decreased anxiety
Improved physical activity
Increased walking speed
Improved pain
Improved disability score
Decreased depressive symptoms

n=439

Aerobic

Increased self-efficacy for stair climbing

n=20

Topp
et al.
(2005)

n=131

Resistance Decreased pain
Decreased stiffness
Decrased arthritis activity (OASI; AIMS)
Increased strength
Increased mobility
Resistance Increased function
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Appendix 2 (continued): Reported outcomes of exercise in persons with OA
Study
Ettinger
et al.
(1997)
Penninx
et al.
(2002)
Topp
et al.
(2002)

Sample
Type of
Outcomes
Size
Exercise
n=439
Resistance Improved disability score
Improved strength
Improved pain
Improved six minute walk test
n=439
Resistance Decreased depressive symptoms
n= 64

Gur
et al.
(2002)

n= 23

Eyigor
et al.
(2004)

n= 44

Foley
n=105
et al.
(2003)
Cochrane n= 106
et al.
(2005)
Diracoglu n=66
et al.
(2005)

Diracoglu
et al.
(2005)

n=66

Resistance Decreased time to ascend and descend
stairs
Decreased knee pain
Improved WOMAC score
Improve time to stand up from floor
Resistance Decreased pain, improved chair rise
Improved walking
Improved stair climb
Increased strength
Resistance Improved strength
Decreased disease severity
Decreased pain
Improved walking time
Improved WOMAC score
Improved SF-36 score
Improved AIMS2 score
WaterImproved function
based
Improved walking distance
Improved physical component on SF-12
WaterImproved pain
based
Improved physical function
Improved patient satisfaction
Functional Decreased time for ADL
Improved strength
Improved WOMAC score
Improved proprioception
Improved stair climb
Improved 10 meter walk time
Resistance Decreased time for ADL
Improved strength
Improved WOMAC score
Improved proprioception
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Appendix 2 (continued): Reported outcomes of exercise in persons with OA
Study
Lin et al.
(2005)

Sample
Size
n=81

Type of
Exercise
Functional

Outcomes
Improved joint position sense
Improved WOMAC functional score
Improved walking speed
Improved muscle strength
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Appendix 3: Mouse models used to study OA
Mechanism
Spontaneous
STR/ort
unidentified
C57/Bl
unidentified
Manipulation of Cartilage Specific Genes
Cho/+
deletion in the Col XIa1 gene
Dmm/+
deletion in the Col IIa1 gene
Cmd/+
deletion in the aggrecan gene
Del 1
Type II collagen deficiency
ADAMTS5 -/ADAMTS5 deficiency
Col2a1 +/Col2a1 deficiency
Col 2a 1
overexpression of Col2a1 gene
Surgical Models
ACL-T
Instability via transection of ACL
PMM
Instability via removal of part of
the medial meniscus
MM
Instability via removal of the
medial meniscus
MCL-T + PMM
Instability via transection of ACL
and part of medial meniscus
Chemical Induced Models
Quinolone
Intra-articular injection of
quinolone antibiotics
MIA
Intra-articular injection of
monosodium iodoacetate
Collagenase
Intra-articular injection of
collagenase
TGF- β1
Intra-articular injection of TGFβ1
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Appendix 4: Poster presented at the International Conference on Preclinical
Models of Osteoarthritis, May 2006
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Appendix 5: Poster Presented at the Annual Meeting of the Orthopedic Research
Society, February 2007
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Appendix 6: Poster presented at the American College of Rheumatology Annual
Scientific Meeting, November 2007
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Appendix 7: Poster presented at the Annual Meeting of the Orthopedic Research
Society, March 2008
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